Publications: Phillips, Elizabeth

2022

Sooda, A., Rwandamuriye, F., Wanjalla, C.N., Jing, L., Koelle, D.M., Peters, B., Leary, S., Chopra, A., Calderwood, M.A., Mallal, S.A., Pavlos, R., Watson, M.ORCID: 0000-0002-6438-9225, Phillips, E.J. and Redwood, A.J. (2022) Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors. Communications Biology, 5 (1). Art. 133.

Phillips, E.J., Demoly, P. and Torres, M.J (2022) Addressing beta‐lactam allergy: A time for action. Allergy, 77 (4). pp. 1091-1093.

Corey, K.B., Koo, G. and Phillips, E.J. (2022) Adverse Events and Safety of SARS-Cov2 Vaccines: What’s New and What’s Next. The Journal of Allergy and Clinical Immunology: In Practice .

Guyer, A.C., Macy, E., White, A.A., Kuruvilla, M.E., Robison, R.G., Kumar, S., Khan, D.A., Phillips, E.J., Ramsey, A. and Blumenthal, K. (2022) Allergy Electronic Health Record Documentation: A 2022 Work Group Report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Krantz, M.S. and Phillips, E.J. (2022) COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA. The Lancet Infectious Diseases, 22 (6). P747-748.

Khan, D.A., Banerji, A., Blumenthal, K.G., Phillips, E.J., Solensky, R., White, A.A., Bernstein, J.A., Chu, D.K., Ellis, A.K., Golden, D.B.K., Greenhawt, M.J., Horner, C.C., Ledford, D., Lieberman, J.A., Oppenheimer, J., Rank, M.A., Shaker, M.S., Stukus, D.R., Wallace, D. and Wang, J. (2022) Drug Allergy: A 2022 Practice Parameter Update. Journal of Allergy and Clinical Immunology .

Hama, N., Abe, R., Gibson, A. and Phillips, E.J. (2022) Drug-Induced Hypersensitivity Syndrome (DIHS)/ Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis. The Journal of Allergy and Clinical Immunology: In Practice, 10 (5). pp. 1155-1167.

Goldman, J.L., Miller, J.O., Miller, N., Eveleigh, R., Gibson, A., Phillips, E.J. and Pastinen, T. (2022) HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure. The Pharmacogenomics Journal, 22 . pp. 124-129.

Porter, M., Choshi, P., Pedretti, S., Chimbetete, T., Smith, R., Meintjes, G., Phillips, E., Lehloenya, R. and Peters, J. (2022) IFN-γ ELISpot in severe cutaneous adverse reactions to First-line Antituberculosis drugs in an HIV endemic setting. Journal of Investigative Dermatology . In Press.

Roy, P., Sidney, J., Lindestam Arlehamn, C.S., Phillips, E., Mallal, S., Armstrong Suthahar, S.S., Billitti, M., Rubiro, P., Marrama, D., Drago, F., Vallejo, J., Suryawanshi, V., Orecchioni, M., Makings, J., Kim, P.J., McNamara, C.A., Peters, B., Sette, A. and Ley, K. (2022) Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B. Circulation Research, 131 (3). pp. 258-276.

Wu, P., Feng, Q., Kerchberger, V.E., Nelson, S.D., Chen, Q., Li, B., Edwards, T.L., Cox, N.J., Phillips, E.J., Stein, C.M., Roden, D.M., Denny, J.C. and Wei, W-Q (2022) Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension. Nature Communications, 13 (1). Art. 46.

Bruusgaard-Mouritsen, M.A., Koo, G., Heinrichsen, A.S., Melchiors, B.B., Krantz, M.S., Plager, J.H., Boxer, M., Phillips, E.J., Stone, C.A. and Garvey, L.H. (2022) Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. The Journal of Allergy and Clinical Immunology: In Practice, 10 (3). P859-862.

Koo, G., Stollings, J.L., Lindsell, C., Dear, M.L., Kripalani, S., Nelson, G.E., McCoy, A.B., Rice, T.W., Phillips, E.J. and Stone, C.A. (2022) Low-Risk penicillin allergy delabeling through direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. The Journal of Allergy and Clinical Immunology: In Practice, 10 (6). pp. 1660-1663.

Zarnegar‐Lumley, S., Stone, C.A., Smith, C.M., Hall, L.L., Luck, K.E., Koo, G., Plager, J.H., Phillips, E.J. and Friedman, D.L. (2022) Oncologist counseling practice and COVID‐19 vaccination outcomes for patients with history of PEG‐asparaginase hypersensitivity. Pediatric Blood & Cancer, 69 (7). Art. e29686.

Deshpande, P., Li, Y., Thorne, M., Palubinsky, A.M., Phillips, E.J. and Gibson, A. (2022) Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity. The Journal of Allergy and Clinical Immunology: In Practice .

Phillips, E.J. and Walter, J.E. (2022) Precision medicine in allergy and immunology through the lens of immunogenomics. The Journal of Allergy and Clinical Immunology: In Practice, 10 (7). pp. 1776-1777.

Koo, G., Plager, J., Fahrenholz, J.M., Phillips, E. and Stone, C. (2022) Reactivity to heparin in patients with alpha-gal allergy. Annals of Allergy, Asthma & Immunology, 129 (4). pp. 515-517.

Lehloenya, R.J., Phillips, E.J., Pasieka, H.B. and Peter, J. (2022) Recognizing Drug Hypersensitivity in Pigmented Skin. Immunology and Allergy Clinics of North America, 42 (2). pp. 219-238.

Koo, G., Yu, R., Phillips, E. and Stone, C.A. (2022) Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks. The Journal of Allergy and Clinical Immunology: In Practice .

Stollings, J.L., Koo, G., Lindsell, C.J., Dear, M.L., McCoy, A., Rice, T.W., Phillips, E.J. and Stone, C.A. (2022) Risk-Stratified Management to Remove Low-Risk Penicillin Allergy Labels in the Patients with COVID-19 in the Intensive Care Unit. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Tarke, A., Coelho, C.H., Zhang, Z., Dan, J.M., Yu, E.D., Methot, N., Bloom, N.I., Goodwin, B., Phillips, E., Mallal, S., Sidney, J., Filaci, G., Weiskopf, D., da Silva Antunes, R., Crotty, S., Grifoni, A. and Sette, A. (2022) SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell, 185 (5). P847-859.

Hertzman, R.J., Deshpande, P., White, K.D., Gangula, R., Chopra, A., Ram, R., Zic, J.A., Zwerner, J.P., Gibson, A. and Phillips, E.J. (2022) Single-cell immunopathology of systemic contact allergy associated with corticosteroids. Journal of Dermatological Science, 105 (2). pp. 137-140.

Gibson, A., Li, Y., Thorne, M., Ram, R., Palubinsky, A., Choshi, P., Porter, M., Trubiano, J., Deshpande, P., Chopra, A., Leary, S., Gangula, R., White, K., Pilkington, M., Konvinse, K., Wang, C-W, Pan, R-Y, Hung, S-I, Chung, W-H, Peter, J., Mallal, S. and Phillips, E. (2022) Single-cell multi-omic approaches define common molecular and cellular signals of dominant antigen-driven cells at the site of drug-induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) tissue damage. Journal of Allergy and Clinical Immunology, 149 (2). Art. AB181.

Phillips, E.J., Bouchard, C.S. and Divito, S.J. (2022) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward. JAMA Dermatology, 158 (6). pp. 607-608.

James, F., Goh, M.S.Y., Mouhtouris, E., Vogrin, S., Chua, K.Y.L., Holmes, N.E., Awad, A., Copaescu, A-M, De Luca, J.F., Zubrinich, C., Gin, D., Cleland, H., Douglas, A., Kern, J.S., Katelaris, C.H., Thien, F., Barnes, S., Yun, J., Tong, W., Smith, W.B, Carr, A., Anderson, T., Legg, A., Bourke, J., Mackay, L.K., Aung, A.K., Phillips, E.J. and Trubiano, J. (2022) Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR). BMJ Open, 12 (8). Art. e055906.

Copaescu, A-M, James, F., Vogrin, S., Rose, M., Chua, K., Holmes, N.E., Turner, N.A., Stone, C., Phillips, E. and Trubiano, J. (2022) Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol. BMJ Open, 12 (8). Art. e063784.

Copaescu, A.M., Rosa Duque, J.S. and Phillips, E.J. (2022) What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccine. Annals of Allergy, Asthma & Immunology, 129 (1). P40-51.

Mukherjee, E.M. and Phillips, E.J. (2022) Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis? Annals of Allergy, Asthma & Immunology, 129 (3). pp. 269-270.

Corey, K.B., Koo, G., Stone, C.A., Kroop, S.F., Fissell, W.H., Kozlowski, S., Zhou, Z-H and Phillips, E.J. (2022) A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies. Annals of Allergy, Asthma & Immunology . In Press.

Li, Y., Deshpande, P., Chopra, A., Choo, L., Gibson, A. and Phillips, E.J. (2022) A low‐cost, sensitive and specific PCR ‐based tool for rapid clinical detection of HLA‐B*35 alleles associated with delayed drug hypersensitivity reactions. HLA .

2021

Copaescu, A.M., Phillips, E.J. and Trubiano, J.A. (2021) Antifungal hypersensitivity reactions and cross-reactivity patterns. Current Opinion in Infectious Diseases, 34 (6). pp. 559-572.

Awad, A., Mouhtouris, E., Nguyen-Robertson, C.V., Holmes, N., Chua, K.Y.L., Copaescu, A., James, F., Goh, M.S., Aung, A.K., Godfrey, D.I., Phillips, E.J., Gibson, A., Almeida, C.F. and Trubiano, J.A. (2021) Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis. Journal of Allergy and Clinical Immunology: Global . In Press.

Singhania, A., Dubelko, P., Kuan, R., Chronister, W.D., Muskat, K., Das, J., Phillips, E.J., Mallal, S.A., Seumois, G., Vijayanand, P., Sette, A., Lerm, M., Peters, B. and Lindestam Arlehamn, C. (2021) CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature. EBioMedicine, 74 . Art. 103746.

Tarke, A., Sidney, J., Kidd, C.K., Dan, J.M., Ramirez, S.I., Yu, E.D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., Methot, N., Phillips, E., Mallal, S., Frazier, A., Rawlings, S.A., Greenbaum, J.A., Peters, B., Smith, D.M., Crotty, S., Weiskopf, D., Grifoni, A. and Sette, A. (2021) Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports Medicine, 2 (2). Art. 100204.

Nakkam, N., Trubiano, J., Gibson, A. and Phillips, E.J. (2021) Considerations for cross-reactivity between vancomycin and other glycopeptides. The Journal of Allergy and Clinical Immunology: In Practice, 9 (8). Art. 3233.

Chang, W-C, Abe, R., Anderson, P., Anderson, W., Ardern-Jones, M.R., Beachkofsky, T.M., Bellón, T., Biala, A.K., Bouchard, C., Cavalleri, G.L., Chapman, N., Chodosh, J., Choi, H.K., Cibotti, R.R., Divito, S.J., Dewar, K., Dehaeck, U., Etminan, M., Forbes, D., Fuchs, E., Goldman, J.L., Holmes, J.H., Hope, E.A., Hung, S-L, Hsieh, C-L, Iovieno, A., Jagdeo, J., Kim, M.K., Koelle, D.M., Lacouture, M.E., Le Pallec, S., Lehloenya, R.J., Lim, R., Lowe, A., McCawley, J., McCawley, J., Micheletti, R.G., Mockenhaupt, M., Niemeyer, K., Norcross, M.A., Oboh, D., Olteanu, C., Pasieka, H.B., Peters, J., Pirmohamed, M., Rieder, M., Saeed, H.N., Shear, N.H., Shieh, C., Straus, S., Sukasem, C., Sung, C., Trubiano, J.A., Tsou, S-Y, Ueta, M., Volpi, S., Wan, C., Wang, H., Wang, Z-Q, Weintraub, J., Whale, C., Wheatley, L.M., Whyte-Croasdaile, S., Williams, K.B., Wright, G., Yeung, S.N., Zhou, L., Chung, W-H, Phillips, E.J. and Carleton, B.C. (2021) Corrigendum to ‘SJS/TEN 2019: From science to translation’ [J. Dermatol. Sci. 98/1 (2020) 2–12]. Journal of Dermatological Science, 104 (2). pp. 146-147.

Leary, S., Gaudieri, S., Parker, M.D., Chopra, A., James, I., Pakala, S., Alves, E., John, M., Lindsey, B.B., Keeley, A.J., Rowland-Jones, S.L., Swanson, M.S., Ostrov, D.A., Bubenik, J.L., Das, S.R., Sidney, J., Sette, A., de Silva, T.I., Phillips, E. and Mallal, S. (2021) Generation of a novel SARS-CoV-2 Sub-genomic RNA due to the R203K/G204R variant in Nucleocapsid: Homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level. Pathogens and Immunity, 6 (2). pp. 27-49.

Leary, S., Gaudieri, S., Parker, M.D., Chopra, A., James, I., Pakala, S., Alves, E., John, M., Lindsey, B.B., Keeley, A.J., Rowland-Jones, S.L., Swanson, M.S., Ostrov, D.A., Bubenik, J.L., Das, S., Sidney, J., Sette, A., de Silva, T.I., Phillips, E. and Mallal, S. (2021) Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level. bioRxiv: The preprint server for Biology .

Li, Y., Deshpande, P., Hertzman, R.J., Palubinsky, A.M., Gibson, A. and Phillips, E.J. (2021) Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions. Frontiers in Genetics, 12 . Art. 641905.

Caballero, M.L., Krantz, M.S., Quirce, S., Phillips, E. and Stone Jr., C.A. (2021) Hidden Dangers: Recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions. The Journal of Allergy and Clinical Immunology: In Practice, 9 (8). pp. 2968-2982.

Deshpande, P., Hertzman, R.J., Palubinsky, A.M., Giles, J.B., Karnes, J.H., Gibson, A. and Phillips, E.J. (2021) Immunopharmacogenomics: Mechanisms of HLA‐Associated Drug Reactions. Clinical Pharmacology & Therapeutics, 110 (3). pp. 607-615.

Krantz, M.S., Stone, C.A., Abreo, A. and Phillips, E.J. (2021) Reply to ‘‘The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy”. The Journal of Allergy and Clinical Immunology: In Practice, 9 (10). pp. 3849-3850.

Bluestein, S.B., Yu, R., Stone, C.A. and Phillips, E.J. (2021) Reporting of Drug Reaction with Eosinophilia and Systemic Symptoms from 2002-2019 in the FDA Adverse Event Reporting System (FAERS). The Journal of Allergy and Clinical Immunology: In Practice, 9 (8). 3208-3211.e1.

Hertzman, R.J., Deshpande, P., Gibson, A. and Phillips, E.J. (2021) Role of pharmacogenomics in T-cell hypersensitivity drug reactions. Current Opinion in Allergy & Clinical Immunology, 21 (4). pp. 327-334.

Hertzman, R., Deshpande, P., White, K., Gangula, R., Chopra, A., Ram, R., Leary, S., Zic, J., Zwerner, J., Gibson, A. and Phillips, E. (2021) Single-cell immunopathology of systemic contact allergy associated with corticosteroids. Journal of Allergy and Clinical Immunology, 147 (2). AB31.

Singhania, A., Pham, J., Dhanwani, R., Frazier, A., Rezende Dutra, J., Marder, K.S., Phillips, E., Mallal, S., Amara, A.W., Standaert, D.G., Sulzer, D., Peters, B., Sette, A. and Lindestam Arlehamn, C.S. (2021) The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse. Scientific Reports, 11 (1). Art. 302.

Hertzman, R.J., Deshpande, P., Leary, S., Li, Y., Ram, R., Chopra, A., Cooper, D., Watson, M.ORCID: 0000-0002-6438-9225, Palubinsky, A.M., Mallal, S., Gibson, A. and Phillips, E.J. (2021) Visual genomics analysis studio as a tool to analyze multiomic data. Frontiers in Genetics, 12 . Art. 642012.

Koo, G., Anvari, S., Friedman, D.L., Zarnegar-Lumley, S., Szafron, V., Kahwash, B.M., Onasch, K.M., Hall, L., Phillips, E.J. and Stone, C.A. (2021) mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to Pegaspargase. The Journal of Allergy and Clinical Immunology: In Practice, 10 (1). P322-P325.

Copaescu, A., Mouhtouris, E., Vogrin, S., James, F., Chua, K.Y.L., Holmes, N.E., Douglas, A., Slavin, M.A., Cleland, H., Zubrinich, C., Aung, A.K., Goh, M.S.Y., Phillips, E.J. and Trubiano, J.A. (2021) The role of In Vivo and Ex Vivo diagnostic tools in severe delayed Immune-Mediated adverse antibiotic drug reactions. The Journal of Allergy and Clinical Immunology: In Practice, 9 (5). 2010-2015.e4.

Copaescu, A., Gibson, A., Li, Y., Trubiano, J.A. and Phillips, E.J. (2021) An updated review of the diagnostic methods in delayed drug hypersensitivity. Frontiers in Pharmacology, 11 . Art. 573573.

2020

Nicoletti, P., Carr, D.F., Barrett, S., McEvoy, L., Friedmann, P.S., Shear, N.H., Nelson, M.R., Chiriac, A.M., Blanca-López, N., Cornejo, J.A., Gaeta, F., Nakonechna, A., Torres, M.J., Caruso, C., Valluzzi, R.L., Floratos, A., Shen, Y., Pavlos, R.K., Phillips, E.J., Demoly, P., Romano, A., Blanca, M. and Pirmohamed, M. (2020) Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort. Journal of Allergy and Clinical Immunology, 147 (5). 1830-1837.e15.

Barakat, L., Torres, M.J., Phillips, E.J., Caminati, M., Chang, Y-S, Caimmi, D., Sanchez-Borges, M., Rosenwasser, L., Didier, A., de Blay, F., Fontaine, J-F, Bosse, I., Lefevre, S., Bassani, C., De Filippo, M., Ansotegui, I., Morais-Almeida, M., Ebisawa, M., Martin, B., Yu-Hor Thong, B., Demoly, P. and Tanno, L.K. (2020) Biological treatments in allergy: Prescribing patterns and management of hypersensitivity reactions. The Journal of Allergy and Clinical Immunology: In Practice, 9 (3). 1396-1399.e2.

Krantz, M.S., Stone, C.A., Yu, R., Adams, S.N. and Phillips, E.J. (2020) Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic. The Journal of Allergy and Clinical Immunology: In Practice, 9 (2). 1024-1028.e3.

Nakkam, N., Gibson, A., Mouhtouris, E., Konvinse, K., Holmes, N., Chua, K.Y., Deshpande, P., Li, D., Ostrov, D.A., Trubiano, J. and Phillips, E.J. (2020) Cross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A*32:01 positive vancomycin DRESS patients sharing an HLA-Class II haplotype. Journal of Allergy and Clinical Immunology, 147 (1). P403-P405.

Lehloenya, R.J., Peter, J.G., Copascu, A., Trubiano, J.A. and Phillips, E.J. (2020) Delabeling delayed drug hypersensitivity: How far can you safely go? The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). 2878-2895.e6.

Copaescu, A., Rose, M., Mouhtouris, E., Chua, K.Y., Holmes, N.E., Phillips, E.J. and Trubiano, J.A. (2020) Delayed hypersensitivity associated with amoxicillin‐clavulanate. Allergy . Early View.

Trubiano, J.A., Vogrin, S., Chua, K.Y.L., Bourke, J., Yun, J., Douglas, A., Stone, C.A., Yu, R., Groenendijk, L., Holmes, N.E. and Phillips, E.J. (2020) Development and validation of a penicillin allergy clinical decision rule. JAMA Internal Medicine, 180 (5). pp. 745-752.

Mangan, B.L., McAlister, R.K., Balko, J.M., Johnson, D.B., Moslehi, J.J., Gibson, A. and Phillips, E.J. (2020) Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy. British Journal of Clinical Pharmacology . Early View.

Krebs, K., Bovijn, J., Zheng, N., Lepamets, M., Censin, J.C., Jürgenson, T., Särg, D., Abner, E., Laisk, T., Luo, Y., Skotte, L., Geller, F., Feenstra, B., Wang, W., Auton, A., Raychaudhuri, S., Esko, T., Metspalu, A., Laur, S., Roden, D.M., Wei, W-Q, Holmes, M.V., Lindgren, C.M., Phillips, E.J., Mägi, R., Milani, L., Fadista, J., Agee, M., Aslibekyan, S., Bell, R.K., Bryc, K., Clark, S.K., Elson, S.L., Fletez-Brant, K., Fontanillas, P., Furlotte, N.A., Gandhi, P.M., Heilbron, K., Hicks, B., Hinds, D.A., Huber, K.E., Jewett, E.M., Jiang, Y., Kleinman, A., Lin, K-H, Litterman, N.K., Luff, M.K., McCreight, J.C., McIntyre, M.H., McManus, K.F., Mountain, J.L., Mozaffari, S.V., Nandakumar, P., Noblin, E.S., Northover, C.A.M., O’Connell, J., Petrakovitz, A.A., Pitts, S.J., Poznik, G.D., Sathirapongsasuti, J.F., Shastri, A.J., Shelton, J.F., Shringarpure, S., Tian, C., Tung, J.Y., Tunney, R.J., Vacic, V., Wang, X. and Zare, A.S. (2020) Genome-wide study identifies association between HLA-B∗55:01 and Self-Reported Penicillin Allergy. The American Journal of Human Genetics, 107 (4). pp. 612-621.

Voic, H., de Vries, R.D., Sidney, J., Rubiro, P., Moore, E., Phillips, E., Mallal, S., Schwan, B., Weiskopf, D., Sette, A., Grifoni, A. and Goodrum, F. (2020) Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination. Journal of Virology, 94 (24).

Mateus, J., Grifoni, A., Voic, H., Angelo, M.A., Phillips, E., Mallal, S., Sidney, J., Sette, A. and Weiskopf, D. (2020) Identification of novel yellow fever Class II epitopes in YF-17D vaccinees. Viruses, 12 (11). Article 1300.

Pavlos, R., Deshpande, P., Chopra, A., Leary, S., Strautins, K., Nolan, D., Thorborn, D., Shaefer, M., Rauch, A., Dunn, D., Montaner, J., Rachlis, A., Almeida, C.M., Choo, L., James, I., Redwood, A.J., Li, Y., Gaudieri, S., Mallal, S.A. and Phillips, E.J. (2020) New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals. Human Immunology, 81 (6). pp. 300-304.

Blumenthal, K.G., Harkness, T., Phillips, E.J., Ramsey, A., Banerji, A., Samarakoon, U., Stone, C., Fu, X., Khan, D.A., Otani, I., Camargo, C.A., Zhang, Y. and Donelan, K. (2020) Patient characteristics and concerns about drug allergy: A report from the United States drug allergy registry. The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). pp. 2958-2967.

Coleman, D.T., Stone, C.A., Wei, W-Q and Phillips, E.J. (2020) Penicillin allergy labels drive perioperative prophylactic antibiotic selection in orthopedic procedures. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Blumenthal, K.G. and Phillips, E. (2020) Positioning drug allergy delabeling as a critical tool for precision medicine, quality improvement, and public health. The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). pp. 2916-2919.

Trubiano, J.A., Vogrin, S., Chua, K.Y.L., Bourke, J., Yun, J., Douglas, A., Stone, C.A., Yu, R., Groenendijk, L., Holmes, N.E., Phillips, E.J. and Resnick, M.J. (2020) Re: Development and validation of a penicillin allergy clinical decision rule. Journal of Urology, 204 (4). p. 869.

Coleman, D.T., Stone, C.A., Wei, W-Q and Phillips, E.J. (2020) Readiness for PENicillin allergy testing: Perception of Allergy Label (PEN-PAL) Survey. The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). 3180-3182.e4.

Cimino, C., Allos, B.M. and Phillips, E.J. (2020) A Review of β-Lactam–Associated Neutropenia and Implications for Cross-reactivity. Annals of Pharmacotherapy, 55 (8). pp. 1037-1049.

Stone, C.A., Stollings, J.L., Lindsell, C. J., Dear, M.L., Buie, R.B., Rice, T.W. and Phillips, E.J. (2020) Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU. American Journal of Respiratory and Critical Care Medicine, 201 (12). pp. 1572-1575.

Chang, W-C, Abe, R., Anderson, P., Anderson, W., Ardern-Jones, M.R., Beachkofsky, T.M., Bellón, T., Biala, A.K., Bouchard, C., Cavalleri, G.L., Chapman, N., Chodosh, J., Choi, H.K., Cibotti, R.R., Divito, S.J., Dewar, K., Dehaeck, U., Etminan, M., Forbes, D., Fuchs, E., Goldman, J.L., Holmes, J.H., Hope, E.A., Hung, S-I, Hsieh, C-L, Iovieno, A., Jagdeo, J., Kim, M.K., Koelle, D.M., Lacouture, M.E., Le Pallec, S., Lehloenya, R.J., Lim, R., Lowe, A., McCawley, J., McCawley, J., Micheletti, R.G., Mockenhaupt, M., Niemeyer, K., Norcross, M.A., Oboh, D., Olteanu, C., Pasieka, H.B., Peter, J., Pirmohamed, M., Rieder, M., Saeed, H.N., Shear, N.H., Shieh, C., Straus, S., Sukasem, C., Sung, C., Trubiano, J.A., Tsou, S-Y, Ueta, M., Volpi, S., Wan, C., Wang, H., Wang, Z-Q, Weintraub, J., Whale, C., Wheatley, L.M., Whyte-Croasdaile, S., Williams, K.B., Wright, G., Yeung, S.N., Zhou, L., Chung, W-H, Phillips, E.J. and Carleton, B.C. (2020) SJS/TEN 2019: From Science to Translation. Journal of Dermatological Science, 98 (1). pp. 2-12.

Vethody, C., Yu, R., Keck, J.M., Onasch, M.K., Stone, C.A. and Phillips, E.J. (2020) Safety, efficacy and effectiveness of delabeling in patients with multiple drug allergy labels. The Journal of Allergy and Clinical Immunology: In Practice, 9 (2). pp. 922-928.

Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S.I., Dan, J.M., Burger, Z.C., Rawlings, S.A., Smith, D.M., Phillips, E., Mallal, S., Lammers, M., Rubiro, P., Quiambao, L., Sutherland, A., Yu, E.D., da Silva Antunes, R., Greenbaum, J., Frazier, A., Markmann, A.J., Premkumar, L., de Silva, A., Peters, B., Crotty, S., Sette, A. and Weiskopf, D. (2020) Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science, 370 (6512). pp. 89-94.

Lindestam Arlehamn, C.S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K.S., Amara, A.W., Standaert, D.G., Goldman, J.G., Litvan, I., Peters, B., Sulzer, D. and Sette, A. (2020) α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease. Nature Communications, 11 (1). pp. 1-11.

Stone, C.A., Trubiano, J.A. and Phillips, E.J. (2020) Testing strategies and predictors for evaluating immediate and delayed reactions to cephalosporins. The Journal of Allergy and Clinical Immunology: In Practice, 9 (1). 435-444.e13.

Stone, C.A., Trubiano, J., Coleman, D.T., Rukasin, C.R.F. and Phillips, E.J. (2020) The challenge of de‐labeling penicillin allergy. Allergy, 75 (2). pp. 273-288.

Chua, K.Y.L., Vogrin, S., Bury, S., Douglas, A., Holmes, N.E., Tan, N., Brusco, N.K., Hall, R., Lambros, B., Lean, J., Stevenson, W., Devchand, M., Garrett, K., Thursky, K., Grayson, M.L., Slavin, M.A., Phillips, E.J. and Trubiano, J.A. (2020) The penicillin allergy delabeling program: A Multicenter Whole-of-Hospital health services intervention and comparative effectiveness study. Clinical Infectious Diseases, 73 (3). pp. 487-496.

Copaescu, A., Smibert, O., Gibson, A., Phillips, E.J. and Trubiano, J.A. (2020) The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. Journal of Allergy and Clinical Immunology, 146 (3). 518-534.e1.

2019

Trubiano, J.A., Gordon, C.L., Castellucci, C., Christo, S.N., Park, S.L., Mouhtouris, E., Konvinse, K., Rose, M., Goh, M., Boyd, A.S., Phillips, E.J. and Mackay, L.K. (2019) Analysis of Skin-Resident memory T Cells following drug hypersensitivity reactions. Journal of Investigative Dermatology, 140 (7). P1442-1445.

Blumenthal, K.G., Peter, J.G., Trubiano, J.A. and Phillips, E.J. (2019) Antibiotic allergy. The Lancet, 393 (10167). pp. 183-198.

Karnes, J.H., Miller, M.A., White, K.D., Konvinse, K.C., Pavlos, R.K., Redwood, A.J., Peter, J.G., Lehloenya, R., Mallal, S.A. and Phillips, E.J. (2019) Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Annual Review of Pharmacology and Toxicology, 59 (1). pp. 463-486.

Trubiano, J.A., Slavin, M.A., Thursky, K.A., Grayson, M.L. and Phillips, E.J. (2019) Beta-Lactam and sulfonamide allergy testing should be a standard of care in immunocompromised host. The Journal of Allergy and Clinical Immunology: In Practice, 7 (7). pp. 2151-2153.

Grifoni, A., Moore, E., Voic, H., Sidney, J., Phillips, E., Jadi, R., Mallal, S., De Silva, A.D., De Silva, A.M., Peters, B., Weiskopf, D. and Sette, A. (2019) Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses. Frontiers in Immunology, 10 .

Tian, Y., Babor, M., Lane, J., Seumois, G., Liang, S., Goonawardhana, N.D.S., De Silva, A.D., Phillips, E.J., Mallal, S.A., da Silva Antunes, R., Grifoni, A., Vijayanand, P., Weiskopf, D., Peters, B. and Sette, A. (2019) Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles. Journal of Clinical Investigation, 129 (4). pp. 1727-1741.

Konvinse, K.C., Trubiano, J.A., Pavlos, R., James, I., Shaffer, C.M., Bejan, C.A., Schutte, R.J., Ostrov, D.A., Pilkinton, M.A., Rosenbach, M., Zwerner, J.P., Williams, K.B., Bourke, J., Martinez, P., Rwandamuriye, F., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, Redwood, A.J., White, K.D., Mallal, S.A. and Phillips, E.J. (2019) HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. Journal of Allergy and Clinical Immunology, 144 (1). pp. 183-192.

Somogyi, A.A., Barratt, D.T., Phillips, E.J., Moore, K., Ilyas, F. and Gabb, G.M. (2019) High and variable population prevalence of HLA‐B*56:02 in indigenous Australians and relation to phenytoin‐associated drug reaction with eosinophilia and systemic symptoms. British Journal of Clinical Pharmacology . Early View.

Saeed, H.N., Bouchard, C., Shieh, C., Phillips, E. and Chodosh, J. (2019) Highlights from the 2nd Biennial Stevens Johnson syndrome symposium 2019: SJS/TEN from Science to Translation. The Ocular Surface, 18 (3). pp. 483-486.

Pan, R-Y, Chu, M-T, Wang, C-W, Lee, Y-S, Lemonnier, F, Michels, A.W., Schutte, R., Ostrov, D.A., Chen, C-B, Phillips, E.J., Mallal, S.A., Mockenhaupt, M., Bellón, T., Tassaneeyakul, W., White, K.D., Roujeau, J-C, Chung, W-H and Hung, S-L (2019) Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nature Communications, 10 (1). art. no. 3569.

Lammert, C., McKinnon, E.J., Chalasani, N. and Phillips, E.J. (2019) Novel HLA Class I Alleles Outside the Extended DR3 Haplotype Are Protective against Autoimmune Hepatitis. Clinical and Translational Gastroenterology, 10 (6).

Krantz, M.S., Stone, C.A., Abreo, A. and Phillips, E.J. (2019) Oral Challenge with Trimethoprim-Sulfamethoxazole in Patients with “Sulfa” Antibiotic Allergy. The Journal of Allergy and Clinical Immunology: In Practice, 8 (2). pp. 757-760.

Trubiano, J.A., Devchand, M. and Phillips, E.J. (2019) Reply. The Journal of Allergy and Clinical Immunology: In Practice, 7 (6). pp. 2095-2096.

Trubiano, J.A., Chua, K.Y.L., Holmes, N.E., Douglas, A., Mouthoris, E., Goh, M. and Phillips, E.J. (2019) Safety of cephalosporins in penicillin class severe delayed hypersensitivity reactions. The Journal of Allergy and Clinical Immunology: In Practice, 8 (3). 1142-1146.e4.

Redwood, A.J., Rwandamuriye, F., Chopra, A., Leary, S., Ram, R., McDonnell, W., Konvinse, K., White, K., Pavlos, R., Koelle, D.M., Mallal, S. and Phillips, E. (2019) Single cell transcriptomics reveal polyclonal memory T cell responses in abacavir patch test positive skin. Journal of Allergy and Clinical Immunology, 144 (5). 1413-1416.e7.

Rukasin, C.R.F., Phillips, E.J. and Norton, A.E. (2019) Slow graded reintroduction of oxcarbazepine for delayed maculopapular eruption. Annals of Allergy, Asthma & Immunology, 123 (4). pp. 411-412.

Trubiano, J.A., Ostrov, D.A. and Phillips, E. (2019) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms. Journal of Allergy and Clinical Immunology: In Practice, 7 (8). pp. 2854-2856.

Stone, C.A., Choudhary, S., Patterson, M.F., Rukasin, C.R.F., Coleman, D.T., Phillips, E.J. and Commins, S.P. (2019) Tolerance of porcine pancreatic enzymes despite positive skin testing in Alpha-gal allergy. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Lindestam Arlehamn, C.S., Pham, J., Alcalay, R.N., Frazier, A., Shorr, E., Carpenter, C., Sidney, J., Dhanwani, R., Agin-Liebes, J., Garretti, F., Amara, A.W., Standaert, D.G., Phillips, E.J., Mallal, S.A., Peters, B., Sulzer, D. and Sette, A. (2019) Widespread Tau-Specific CD4 T Cell Reactivity in the General Population. The Journal of Immunology, 203 (1). pp. 84-92.

Rwandamuriye, F.X., Chopra, A., Konvinse, K.C., Choo, L., Trubiano, J.A., Shaffer, C.M., Watson, M.ORCID: 0000-0002-6438-9225, Mallal, S.A. and Phillips, E.J. (2019) A rapid allele-specific assay for HLA-A*32:01 to identify patients at risk for vancomycin-induced Drug Reaction with Eosinophilia and systemic symptoms. The Journal of Molecular Diagnostics, 21 (5). pp. 782-789.

2018

Phillips, E.J. and Mallal, S.A. (2018) Active suppression rather than ignorance: Tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration. Journal of Clinical Investigation, 128 (7). pp. 2746-2749.

Stone, C.A., Commins, S.P., Choudhary, S., Vethody, C., Heavrin, J.L., Wingerter, J., Hemler, J.A., Babe, K., Phillips, E.J. and Norton, A.E. (2018) Anaphylaxis after vaccination in a pediatric patient: further implicating Alpha-Gal allergy. The Journal of Allergy and Clinical Immunology: In Practice, 7 (1). pp. 322-324.

Norton, A.E., Konvinse, K., Phillips, E.J. and Broyles, A.D. (2018) Antibiotic allergy in pediatrics. Pediatrics, 141 (5).

Trubiano, J.A, Grayson, M.L., Phillips, E.J., Stewardson, A.J., Thursky, K.A. and Slavin, M.A. (2018) Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer. Journal of Antimicrobial Chemotherapy, 73 . pp. 3209-3211.

Vyles, D., Chiu, A., Routes, J., Castells, M., Phillips, E.J., Kibicho, J. and Brousseau, D.C. (2018) Antibiotic use after removal of penicillin allergy label. Pediatrics, 141 (5).

Phillips, E.J., Sukasem, C., Whirl-Carrillo, M., Müller, D.J., Dunnenberger, H.M., Chantratita, W., Goldspiel, B., Chen, Y-T, Carleton, B.C., George, A.L., Mushiroda, T., Klein, T., Gammal, R.S. and Pirmohamed, M. (2018) Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. Clinical Pharmacology & Therapeutics, 103 (4). pp. 574-581.

Trubiano, J.A., Grayson, M.L., Thursky, K.A., Phillips, E.J. and Slavin, M.A. (2018) How antibiotic allergy labels may be harming our most vulnerable patients. The Medical Journal of Australia, 208 (11). pp. 469-470.

Cook, K.M., Gillon, J., Grisso, A.G., Banerjee, R., Jimenez-Truque, N., Phillips, E.J. and Van Driest, S.L. (2018) Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin–Tazobactam or Cefepime: A Cohort Study. Journal of the Pediatric Infectious Diseases Society . In Press.

Kim, W.B., Worley, B., Holmes, J., Phillips, E.J. and Beecker, J. (2018) Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis. Journal of the American Academy of Dermatology, 79 (6). pp. 1150-1152.

Devchand, M., Urbancic, K.F., Khumra, S., Douglas, A.P., Smibert, O., Cohen, E., Sutherland, M., Phillips, E.J. and Trubiano, J.A. (2018) Pathways to improved antibiotic allergy and antimicrobial stewardship practice: The validation of a beta-lactam antibiotic allergy assessment tool. The Journal of Allergy and Clinical Immunology: In Practice, 7 (3). pp. 1063-1065.

Redwood, A., Trubiano, J. and Phillips, E. (2018) Prevention and diagnosis of severe T-Cell-Mediated adverse drug reactions: Are we there yet? Journal of Allergy and Clinical Immunology: In Practice, 7 (1). pp. 228-230.

Stone, C.A., Hemler, J.A., Commins, S.P., Schuyler, A.J., Phillips, E.J., Peebles, R.S. and Fahrenholz, J.M. (2018) Reply. Journal of Allergy and Clinical Immunology, 141 (5). pp. 1957-1958.

White, K.D., Abe, R., Ardern-Jones, M., Beachkofsky, T., Bouchard, C., Carleton, B., Chodosh, J., Cibotti, R., Davis, R., Denny, J.C., Dodiuk-Gad, R.P., Ergen, E.N., Goldman, J.L., Holmes, J.H., Hung, S-L, Lacouture, M.E., Lehloenya, R.J., Mallal, S., Manolio, T.A., Micheletti, R.G., Mitchell, C.M., Mockenhaupt, M., Ostrov, D.A., Pavlos, R., Pirmohamed, M., Pope, E., Redwood, A., Rosenbach, M., Rosenblum, M.D., Roujeau, J-C, Saavedra, A.P., Saeed, H.N., Struewing, J.P., Sueki, H., Sukasem, C., Sung, C., Trubiano, J.A., Weintraub, J., Wheatley, L.M., Williams, K.B., Worley, B., Chung, W-H, Shear, N.H. and Phillips, E.J. (2018) SJS/TEN 2017: Building multidisciplinary networks to drive science and translation. The Journal of Allergy and Clinical Immunology: In Practice, 6 (1). pp. 38-69.

Grifoni, A., Sidney, J., Carpenter, C., Phillips, E., Mallal, S., Scriba, T.J., Sette, A. and Lindestam Arlehamn, C.S. (2018) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 159 individuals from the Worcester region of the Western Cape province of South Africa. Human Immunology, 79 (3). pp. 143-144.

Weiskopf, D., Grifoni, A., Arlehamn, C.S.L., Angelo, M., Leary, S., Sidney, J., Frazier, A., Mack, S.J., Phillips, E., Mallal, S., Cerpas, C., Balmaseda, A., Harris, E. and Sette, A. (2018) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 339 adults from Managua, Nicaragua. Human Immunology, 79 (1). pp. 1-2.

Moore, E., Grifoni, A., Weiskopf, D., Schulten, V., Arlehamn, C.S.L., Angelo, M., Pham, J., Leary, S., Sidney, J., Broide, D., Frazier, A., Phillips, E., Mallal, S., Mack, S.J. and Sette, A. (2018) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USA. Human Immunology, 79 (12). pp. 821-822.

White, K.D., Konvinse, K.C., Pilkinton, M.A., Redwood, A., Trubiano, J.A., Peter, J.G., Lehloenya, R., Chung, W-H, Hung, S-L, Pan, R-Y, Chopra, A., Barnett, L., Gangula, R., Mallal, S.A. and Phillips, E.J. (2018) Single cell approaches to define the pathogenic immune cells that mediate drug hypersensitivity. Journal of Allergy and Clinical Immunology, 141 (2). AB88.

Adams, S.N., McKinnon, E. and Phillips, E.J. (2018) Testing strategies for patients labeled as allergic To fluoroquinolones. Journal of Allergy and Clinical Immunology, 141 (2).

da Silva Antunes, R., Pham, J., McMurtrey, C., Hildebrand, W.H., Phillips, E., Mallal, S., Sidney, J., Busse, P., Peters, B., Schulten, V. and Sette, A. (2018) Urinary peptides as a novel source of T Cell allergen epitopes. Frontiers in Immunology, 9 .

Trubiano, J.A., Strautins, K., Redwood, A.J., Pavlos, R., Konvinse, K.C., Aung, A.K., Slavin, M.A., Thursky, K.A., Grayson, M.L. and Phillips, E.J. (2018) The combined utility of Ex Vivo IFN-γ release Enzyme-Linked ImmunoSpot assay and In Vivo skin testing in patients with Antibiotic-Associated severe cutaneous adverse reactions. The Journal of Allergy and Clinical Immunology: In Practice, 6 (4). pp. 1287-1296.

Trubiano, J.A., Douglas, A.P., Goh, M., Slavin, M.A. and Phillips, E.J. (2018) The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts. The Journal of Allergy and Clinical Immunology: In Practice, 7 (4). pp. 1341-1343.

Derrick, M.I.P., Williams, K.B., Shade, L.M and Phillips, E.J. (2018) A survey of drug allergy training opportunities in the United States. The Journal of Allergy and Clinical Immunology: In Practice, 6 (1). pp. 302-304.

2017

Trubiano, J.A., Stone, C.A., Grayson, M.L., Urbancic, K., Slavin, M.A., Thursky, K.A. and Phillips, E.J. (2017) The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration. The Journal of Allergy and Clinical Immunology: In Practice, 5 (6). pp. 1532-1542.

Pavlos, R., Redwood, A. and Phillips, E. (2017) AdDRESSing T-cell responses to antituberculous drugs. British Journal of Dermatology, 176 (2). pp. 292-293.

Thomas, M., Hopkins, C., Duffy, E., Lee, D., Loulergue, P., Ripamonti, D., Ostrov, D.A. and Phillips, E. (2017) Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. Clinical Infectious Diseases, 64 (9). pp. 1198-1203.

Tseng, A., Hughes, C.A., Wu, J., Seet, J. and Phillips, E.J. (2017) Cobicistat Versus Ritonavir: Similar pharmacokinetic enhancers but some important differences. Annals of Pharmacotherapy, 51 (11). pp. 1008-1022.

Karnes, J.H., Shaffer, C.M., Bastarache, L., Gaudieri, S., Glazer, A.M., Steiner, H.E., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Comparison of HLA allelic imputation programs. PLoS ONE, 12 (2).

Abana, C.O., Pilkinton, M.A., Gaudieri, S., Chopra, A., McDonnell, W.J., Wanjalla, C., Barnett, L., Gangula, R., Hager, C., Jung, D.K., Engelhardt, B.G., Jagasia, M.H., Klenerman, P., Phillips, E.J., Koelle, D.M., Kalams, S.A. and Mallal, S.A. (2017) Cytomegalovirus (CMV) Epitope–Specific CD4 + T Cells Are Inflated in HIV + CMV + Subjects. The Journal of Immunology, 199 (9). pp. 3187-3201.

da Silva Antunes, R., Paul, S., Sidney, J., Weiskopf, D., Dan, J.M., Phillips, E., Mallal, S., Crotty, S., Sette, A. and Lindestam Arlehamn, C.S. (2017) Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect Ex Vivo tetanus CD4+ T cell responses. PLoS ONE, 12 (1).

Somogyi, A.A. and Phillips, E. (2017) Genomic testing as a tool to optimise drug therapy. Australian Prescriber, 40 (3). pp. 101-104.

Grifoni, A., Angelo, M.A., Lopez, B., O’Rourke, P.H., Sidney, J., Cerpas, C., Balmaseda, A., Silveira, C.G.T., Maestri, A., Costa, P.R., Durbin, A.P., Diehl, S.A., Phillips, E., Mallal, S., De Silva, A.D., Nchinda, G., Nkenfou, C., Collins, M.H., de Silva, A.M., Lim, M.Q., Macary, P.A., Tatullo, F., Solomon, T., Satchidanandam, V., Desai, A., Ravi, V., Coloma, J., Turtle, L., Rivino, L., Kallas, E.G., Peters, B., Harris, E., Sette, A. and Weiskopf, D. (2017) Global assessment of dengue Virus-Specific CD4+ T cell responses in Dengue-Endemic areas. Frontiers in Immunology, 8 .

Redwood, A.J., Pavlos, R.K., White, K.D. and Phillips, E.J. (2017) HLAs: Key regulators of T-cell-mediated drug hypersensitivity. HLA, 91 (1). pp. 3-16.

Trubiano, J.A., Thursky, K.A., Stewardson, A.J., Urbancic, K., Worth, L.J., Jackson, C., Stevenson, W., Sutherland, M., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2017) Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clinical Infectious Diseases, 65 (1). pp. 166-174.

Karnes, J.H., Shaffer, C.M., Cronin, R., Bastarache, L., Gaudieri, S., James, I., Pavlos, R., Steiner, H., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin-like receptors (KIR) types on heparin-induced thrombocytopenia (HIT). Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37 (9). pp. 1164-1171.

Grifoni, A., Angelo, M., Sidney, J., Paul, S., Peters, Bjoern, de Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Botten, J., Boyson, J., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and García-Sastre, A. (2017) Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. Journal of Virology, 91 (8).

Trubiano, J.A., Adkinson, N.F. and Phillips, E.J. (2017) Penicillin allergy is not necessarily forever. JAMA, 318 (1). p. 82.

Garon, S.L., Pavlos, R.K., White, K.D., Brown, N.J., Stone, C.A. and Phillips, E.J. (2017) Pharmacogenomics of off-target adverse drug reactions. British Journal of Clinical Pharmacology, 83 (9). pp. 1896-1911.

Grifoni, A., Pham, J., Sidney, J., O'Rourke, P.H., Paul, S., Peters, B., Martini, S.R., de Silva, A.D., Ricciardi, M.J., Magnani, D.M., Silveira, C.G.T., Maestri, A., Costa, P.R., de-Oliveira-Pinto, L.M., de Azeredo, E.L., Damasco, P.V., Phillips, E., Mallal, S., de Silva, A.M., Collins, M., Durbin, A., Diehl, S.A., Cerpas, C., Balmaseda, A., Kuan, G., Coloma, J., Harris, E., Crowe, J.E., Stone, M., Norris, P.J., Busch, M., Vivanco-Cid, H., Cox, J., Graham, B.S., Ledgerwood, J.E., Turtle, L., Solomon, T., Kallas, E.G., Watkins, D.I., Weiskopf, D., Sette, A. and Dermody, T.S. (2017) Prior dengue virus exposure shapes T Cell immunity to Zika Virus in humans. Journal of Virology, 91 (24).

Adler, N.R., Aung, A.K., Ergen, E.N., Trubiano, J., Goh, M.S.Y. and Phillips, E.J. (2017) Recent advances in the understanding of severe cutaneous adverse reactions. British Journal of Dermatology, 177 (5). pp. 1234-1247.

Manolio, T.A., Hutter, C.M., Avigan, M., Cibotti, R., Davis, R.L., Denny, J.C., Grenade, L.L., Wheatley, L.M., Carrington, M.N., Chantratita, W., Chung, W.H., Dalton, A.D., Hung, S.I., Lee, M.T.M., Leeder, J.S., Lertora, J.J.L., Mahasirimongkol, S., McLeod, H.L., Mockenhaupt, M., Pacanowski, Michael, Phillips, E.J., Pinheiro, S., Pirmohamed, M., Sung, C., Suwankesawong, W., Trepanier, L.A., Tumminia, S.J., Veenstra, D., Yuliwulandari, R. and Shear, N.H. (2017) Research directions in genetic predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis. Clinical Pharmacology & Therapeutics, 103 (3). pp. 390-394.

Arlehamn, C.S.L., Copin, R., Leary, S., Mack, S.J., Phillips, E., Mallal, S., Sette, A., Blatner, G., Siefers, H. and Ernst, J.D. (2017) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya. Human Immunology, 78 (4). pp. 325-326.

Grifoni, A., Weiskopf, D., Lindestam Arlehamn, C.S., Angelo, M., Leary, S., Sidney, J., Frazier, A., Phillips, E., Mallal, S., Mack, S.J., Tippalagama, R., Goonewardana, S., Premawansa, S., Premawansa, G., Wijewickrama, A., De Silva, A.D. and Sette, A. (2017) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 714 adults from Colombo, Sri Lanka. Human Immunology, 79 (2). pp. 87-88.

Peter, J.G., Lehloenya, R., Dlamini, S., Risma, K., White, K.D., Konvinse, K.C. and Phillips, E.J. (2017) Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 547-563.

Pavlos, R., White, K.D., Wanjalla, C., Mallal, S.A. and Phillips, E.J. (2017) Severe delayed drug reactions. Immunology and Allergy Clinics of North America, 37 (4). pp. 785-815.

Pavlos, R., McKinnon, E.J., Ostrov, D.A., Peters, B., Buus, S., Koelle, D., Chopra, A., Schutte, R., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Kaever, T., Myers, P., Speers, E., Malaker, S.A., Shabanowitz, J., Jing, Y., Gaudieri, S., Hunt, D.F., Carrington, M., Haas, D.W., Mallal, S. and Phillips, E.J. (2017) Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Scientific Reports, 7 (1).

Sulzer, D., Alcalay, R.N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W.H., Mao, X., Dawson, V.L., Dawson, T.M., Oseroff, C., Pham, J., Sidney, J., Dillon, M.B., Carpenter, C., Weiskopf, D., Phillips, E., Mallal, S., Peters, B., Frazier, A., Lindestam Arlehamn, C.S. and Sette, A. (2017) T cells from patients with Parkinson’s disease recognize α-synuclein peptides. Nature, 546 (7660). pp. 656-661.

Urbancic, K.F., Ierino, F., Phillips, E., Mount, P.F., Mahony, A. and Trubiano, J.A. (2017) Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients. American Journal of Transplantation, 18 (2). pp. 462-466.

2016

Elera, J.D., Boteanu, C., Blanco, M.A.J., Gonzalez-Mendiola, R., García, I.C., Alvarez, A., Martinez, J.J.L., Garrido, J.M., Barona, C.T., Chorda, C.P., Salgueiro, R.L., Palacios, M.D., De Rojas, D.H.F., Acar, E.A., Aktas, A., Ermertcan, A.T., Temiz, C., Lin, C-Y, Hui, C-Y.R., Chang, Y-C, Yang, C-H, Chung, W-H, Carolino, F., Silva, D., De Castro, E.D., Cernadas, J.R., Ensina, L.F., Aranda, C., Nunes, I.C., Lacerda, A., Martins, A.M., Goudouris, E., Ribeiro, M., Da Silva Franco, J.F., Queiroz, L., Solé, D., Dalgiç, C.T., Sin, A.Z., Günsen, F.D., Bulut, G., Ardeniz, F.Ö., Gülbahar, O., Gökmen, E.N.M., Kokuludag, A., De Francisco, A.M.M., De Vicente Jiménez, T.M., Mendoza Parra, A.M., Burgos Pimentel, A.M., Luque, A.G., Amaral, L., Leão, L.C., Pinto, N., Belo, J., Marques, J., Carreiro-Martins, P., Leiria-Pinto, P., Chaabane, A., Romdhane, H.B., Fredj, N.B., Chadly, Z., Boughattas, N.A., Aouam, K., Uyttebroek, A.P., Bridts, C.H., Romano, A., Ebo, D.G., Sabato, V., Lopes, A., Cosme, J., Aguiar, R., Lourenço, T., Paes, M-J, Spínola-Santos, A., Pereira-Barbosa, M., Cruz, C.R., Dos Reis, R.P., Tomaz, E., Pires, A.P., Inácio, F., Benito-Garcia, F., Mota, I., Correia, M., Gaspar, Â., Chambel, M., Piedade, S., Morais-Almeida, M., Nakonechna, A., Antipkin, Y., Umanets, T., Pineda, F., Arribas, F., Lapshyn, V., Miranda, P.A., De La Cruz Hoyos, B., Blanco, A.J., Del Pozo, M., Vultaggio, A., Nencini, F., Pratesi, S., Matucci, A., Maggi, E., Cegec, I., Nahal, D.J., Turk, V.E., Aumiler, M.R., Ausperger, K.M., Kraljickovic, I., Simic, I., Yamaguchi, Y., Watanabe, T., Satoh, M., Tanegashima, T., Oda, K., Wada, H., Aihara, M., Lee, J.J., Choi, J.C., Lee, H.Y., Fernandes, R-A.R., Faria, E., Pita, J., Sousa, N., Ribeiro, C., Carrapatoso, I., Bom, A.T., Rodolfo, A., Dias-Castro, E., Voronova, M., Valle, D.K., Coronel, V.P., Chordá, C.P., Madamba, R.C.Y., Ferrer, M., Goikoetxea, M.J., D’Amelio, C., Bernad, A., Vega, O., Gastaminza, G., Bibián, B.L., Salazar, M.L., Vilà-Nadal, G., Roman, A.M.F., Ortega, J.D., Muñoz, M.G., Gancedo, S.Q., Moreno, M.R.C., Hofmeier, K.S., Barzylovych, V., Pola, B., Lluncor, M., Fiandor, A., Bellón, T., Domínguez, J., Quirce, S., Yang, M-S, Kim, S-S, Kim, S-H, Kang, H-R, Park, H-W, Cho, S-H, Min, K-U, Chang, Y-S, Delahaye, C., Flabbee, J., Waton, J., Bauvin, O., Barbaud, A., Fadhel, N.B., Gulin, S.J., Chiriac, A., Cardoso, B.K., Viseu, R., Moreira, A., Cadinha, S., Neves, A.C., Barreira, P., Malheiro, D., Da Silva, J.P., Jurakic-Toncic, R., Ljubojevic, S., Turcic, P., Gilissen, L., Huygens, S., Goossens, A., Andreu, I., Romero, A.M., Cabezas, P.G., Parejo, P.A., Del Carmen Plaza-Serón, M., Doña, I., Blanca-López, N., Flores, C., Galindo, M.L., Molina, A., Perkins, J.R., Cornejo-García, J.A., García-Agúndez, J.A., García-Martín, E., Campo, P., Canto, M.G., Blanca, M., Guéant-Rodríguez, R.M., Jurado-Escobar, R., Barrionuevo, E., Salas, M., Canto, G., Guéant, J-L, Usui, T., Tailor, A., Faulkner, L., Farrell, J., Alfirevic, A., Kevin Park, B., Naisbitt, D.J., Trelles, O., Guerrero, M.A., Upton, A., Ueta, M., Sawai, H., Sotozono, C., Tokunaga, K., Kinoshita, S., Sukasem, C., Satapornpong, P., Tempark, T., Rerknimitr, P., Pairayayutakul, K., Klaewsongkram, J., Koomdee, N., Jantararoungtong, T., Santon, S., Puangpetch, A., Intusoma, U., Tassaneeyakul, W., Theeramoke, V., Ramirez, E., Borobia, A.M., Tong, H., Castañer, J.L., De Abajo, F.J., Galvao, V.R., Pavlos, R., McKinnon, E., Williams, K., Beeghly-Fadiel, A., Phillips, E., Castells, M., Boni, E., Russello, M., Mauro, M., Ue, K.L., Rutkowski, K., Gomis, V.S., Ferre, J.F., Rodriguez, A.E., Reig, V.C., Sanchez, J.F., Breynaert, C., Van Hoeyveld, E., Schrijvers, R., Blanco, A.J., Irigoyen, R.F., Collado, D., Vida, Y., Najera, F., Perez-Inestrosa, E., Mesa-Antunez, P., Mayorga, C., Torres, M.J., Tannert, L.K., Mortz, C.G., Skov, P.S., Bindslev-Jensen, C., Pfützner, W., Dörnbach, H., Visse, J., Rauber, M., Möbs, C., Elzagallaai, A.A., Chow, L., Abuzgaia, A.M., Rieder, M.J., Trubiano, J., Woolnough, E., Cheng, C., Kato, K., Azukizawa, H., Hanafusa, T., Katayama, I., Fujiyama, T., Hashizume, H., Umayahara, T., Ito, T., Tokura, Y., Silar, M., Zidarn, M., Rupnik, H., Korosec, P., Redwood, A.J., Strautins, K., White, K., Chopra, A., Konvinse, K., Leary, S., Mallal, S., Cabañas, R., Fiandor, A.M., Sullivan, A., Whitaker, P., Peckham, D., Haw, W.Y., Polak, M.E., Mcguire, C., Ardern-Jones, M.R., Aoyama, Y., Shiohara, T., Correia, S., Gelincik, A., Demir, S., Sen, F., Bozbey, H.U., Olgac, M., Unal, D., Coskun, R., Colakoglu, B., Buyuozturk, S., Çatin-Aktas, E., Deniz, G., Laguna, J.J., Dionicio, J., Fernandez, T., Olazabal, I., Ruiz, M.D., Torres, M.J., Lafuente, A., Núñez, J., Fernández, T.D., Palomares, F., Fernández, R., Sanchez, M.I., Fernandez, T., Ruiz, A., Ariza, A., Alonso, A.B., Garófalo, C.D., Matute, O.V., Puga, M.F., Lapresa, M.J.G., Lasarte, G.G., Thinnes, A., Merk, H.F., Baron, J.M., Leverkus, M., Balakirski, G., Gibson, A., Ogese, M., Al-Attar, Z., Yaseen, F., Meng, X., Jenkins, R., Farrel, J., Alhilali, K., Xue, Y., Illing, P., Mifsud, N., Fettke, H., Lai, J., Ho, R., Kwan, P., Purcell, A., Ogese, M.O., Betts, C., Thomson, P., Alhaidari, M., Berry, N., O’Neill, P.M., Alzahrani, A., Azoury, M.E., Fili, L., Bechara, R., Scornet, N., Nhim, C., Weaver, R., Claude, N., Joseph, D., Maillere, B., Parronchi, P., Pallardy, M., Villani, A.P., Rozières, A., Bensaïd, B., Tardieu, M., Albert, F., Mutez, V., Baysal, T., Maryanski, J., Nicolas, J-F, Kanagawa, O., Vocanson, M., Hung, S-L, Harrison, C.J., Jenkins, R.E., French, N.S., Montañez, M.I., Fernandez, T.D., Martin-Serrano, A., Torres, M.J., Molina, N., Wood, S., Pirmohamed, M., Montañez, M.I., Martín-Serrano, Á., Pérez-Inestrosa, E., Pérez-Sala, D., Guzmán, A.E., Ko, T-M, Chen, Y-T, Wu, J-Y, Sánchez-Gómez, F.J., González-Morena, J.M., Torres, M.J., Arreola, A.M., Corona, J.A.B., Flores, S.M., Cherit, J.D., Figueroa, N.V.D., Flores, J.L.C., Perkins, J., Pérez-Alzate, D., Bogas, G., Torres, M.J., Marti, L.M.T., De La Losa, F.P., Poves, F.A., Lopez, J.T. and Santiago, T.L. (2016) 7th Drug hypersensitivity meeting: part two. Clinical and Translational Allergy, 6 (S3).

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Allergic Mechanisms: Characterizing immune responses in severe T-cell mediated adverse drug reaction. In: American Association of Immunologists Conference, (AAI) 2016, 13 - 17 May 2016, Seattle, USA.

Stone, C.A., Hemler, J.A., Commins, S.P., Schuyler, A.J., Phillips, E.J., Peebles, R.S. and Fahrenholz, J.M. (2016) Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism. Journal of Allergy and Clinical Immunology, 139 (5). pp. 1710-1713.

Trubiano, J.A., Beekmann, S.E., Polgren, P.M., Worth, L.J., Grayson, M.L. and Phillips, E.J. (2016) Antibiotic allergy De-Labeling: Teaching an old dog new tricks. Journal of Allergy and Clinical Immunology, 137 (2). AB398.

Galvão, V.R., Phillips, E., Giavina-Bianchi, P. and Castells, M.C. (2016) Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 816-818.

White, K.D., Konvinse, K., Pilkington, M., Barnett, L., Gangula, R., Redwood, A., Pavlos, R., Chopra, A., Mallal, S. and Phillips, E. (2016) Characterization of TCR repertoire diversity and tissue distribution of drug-specific T cells in DRESS. In: 16th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS) 2016, 22 - 26 June 2016, Boston, MA.

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Characterizing immune responses in severe T-cell mediated adverse drug reaction. The Journal of Immunology, 196 (Supp. 1).

Phillips, E.J. (2016) Classifying ADRs - Does dose matter? British Journal of Clinical Pharmacology, 81 (1). pp. 10-12.

Trubiano, J.A., Redwood, A., Strautins, K., Pavlos, R., Woolnough, E., Chang, C.C. and Phillips, E. (2016) Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 823-826.

Redwood, A.J., Trubiano, J.A., Pavlos, R., Woolnough, E., Strautins, K., Chang, C. and Phillips, E. (2016) Enzyme linked Immunospot assay used in the diagnosis of severe cutaneous adverse reactions to antimicrobials. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Jing, L., Laing, K.J., Dong, L., Russell, R.M., Barlow, R.S., Haas, J.G., Ramchandani, M.S., Johnston, C., Buus, S., Redwood, A.J., White, K.D., Mallal, S.A., Phillips, E.J., Posavad, C.M., Wald, A. and Koelle, D.M. (2016) Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses. The Journal of Immunology, 196 (5). pp. 2205-2218.

Phillips, E. (2016) HLA and translation into Drug Hypersensitivity practice. In: European Academy of Allergy and Clinical Immunology Congress (EAACI), 11 - 15 June 2016, Vienna, Austria.

Weiskopf, D., Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., De Silva, A.D., Phillips, E., Mallal, S., Premawansa, S., Premawansa, G., Wijewickrama, A., Peters, B. and Sette, A. (2016) HLA-DRB1 alleles are associated with different magnitudes of dengue Virus–Specific CD4+T-Cell responses. Journal of Infectious Diseases, 214 (7). pp. 1117-1124.

Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., Peters, B., De Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and Frueh, K. (2016) Human CD4 + T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity. Journal of Virology, 91 (5).

Mosley, J.D., Witte, J.S., Larkin, E.K., Bastarache, L., Shaffer, C.M., Karnes, J.H., Stein, C.M., Phillips, E., Hebbring, S.J., Brilliant, M.H., Mayer, J., Ye, Z., Roden, D.M. and Denny, J.C. (2016) Identifying genetically driven clinical phenotypes using linear mixed models. Nature Communications, 7 .

Trubiano, J.A., Beekmann, S.E., Worth, L.J., Polgreen, P.M., Thursky, K.A., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2016) Improving antimicrobial stewardship by antibiotic allergy delabeling: Evaluation of knowledge, attitude, and practices throughout the emerging infections network. Open Forum Infectious Diseases, 3 (3).

Phillips, E. (2016) Improving phenotypic precision & using pharmacogenomics to understand mechanisms of drug hypersensitivity reactions. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Phillips, E. (2016) Improving the prediction of drug action. In: ASCPT, 8 - 12 March 2016, San Diego, USA.

White, K., Redwood, A., Jing, L., Konvinse, K., Pavlos, R., Koelle, D., Mallal, S. and Phillips, E. (2016) Isolation of activated CD8+ T cells following drug stimulation: A first step toward evaluating the heterologous immunity model for pure T-cell mediated adverse drug reactions. In: American Society for Clinical Investigation (ASCI) Meeting, 15 - 17 April 2016, Chicago, IL.

Metushi, I., Uetrecht, J. and Phillips, E. (2016) Mechanism of isoniazid-induced hepatotoxicity: Then and now. British Journal of Clinical Pharmacology, 81 (6). pp. 1030-1036.

Murray, T.S., Rice, T.W., Wheeler, A.P., Phillips, E.J., Dworski, R.T. and Stollings, J.L. (2016) Medication desensitization: Characterization of outcomes and risk factors for reactions. Annals of Pharmacotherapy, 50 (3). pp. 203-208.

Konvinse, K.C., Phillips, E.J., White, K.D. and Trubiano, J.A. (2016) Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity. Current Opinion in Infectious Diseases, 29 (6). pp. 561-576.

Phillips, E. (2016) Pharmacogenomics in drug hypersensitivity practice. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Trubiano, J.A., Worth, L.J., Urbancic, K., Brown, T.M., Paterson, D.L., Lucas, M. and Phillips, E. (2016) Return to Sender: The need to re-address patient antibiotic allergy labels in Australia and New Zealand. Internal Medicine Journal, 46 (11). pp. 1311-1317.

Pham, J., Oseroff, C., Hinz, D., Sidney, J., Paul, S., Greenbaum, J., Vita, R., Phillips, E., Mallal, S., Peters, B. and Sette, A. (2016) Sequence conservation predicts T cell reactivity against ragweed allergens. Clinical & Experimental Allergy, 46 (9). pp. 1194-1205.

Redwood, A., White, K., Strautins, K., Chopra, A., Konvinse, K., Leary, S., Pavlos, R., Mallal, S. and Phillips, E. (2016) Single cell analysis of drug responsive T cells; identification of candidate drug reactive T cell receptors in abacavir and carbamazepine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Pavlos, R., McKinnon, E., Ostrov, D., Peters, B., Buus, S., Koelle, D., Chopra, A., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Yuan, J., Gaudieri, S., Carrington, M., Haas, D., Mallal, S. and Phillips, E. (2016) Specific binding characteristics Of HLA Alleles associated with nevirapine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Phillips, E. (2016) TPS 10 Anaphylaxis in drug hypersensitivity and LB TPS 9 Drug Allergy II. In: European Academy of Allergy and Clinical Immunology Congress (EAACI), 11 - 15 June 2016, Vienna, Austria.

Phillips, E. (2016) Translational drug safety: Predicting and preventing severe immunologically-mediated drug reactions. In: Drug Safety Gordon Research Conference 2016, 26 June - 1 July 2016, Stonehill College, Easton, Massachussetts.

Phillips, E. (2016) Utility of HLA in Pharmacogenomic testing. In: IGNITE Meeting, 27 January 2016, Nashville, Tennessee.

Pavlos, R., Strautins, K., James, I., Mallal, S., Redwood, A.J. and Phillips, E. (2016) Variation in EraP Influencees Risk for HLA-B*57:01 positive abacavir hypersensitivity. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI) 2016, 22 - 25 February 2016, Boston, MA.

Gerace, K., Wang, L. and Phillips, E.J. (2016) The negative impact of persistent penicillin allergy labeling. Journal of Allergy and Clinical Immunology, 137 (2). AB397.

2015

Murray, T., Rice, T., Wheeler, A., Phillips, E., Dworski, R. and Stollings, J. (2015) 626: Drug desensitization outcomes and risk factors for skin reactions in adults. Critical Care Medicine, 43 . p. 158.

Shoukry, N.H., Lucas, A., Lucas, M., Strhyn, A., Keane, N.M., McKinnon, E., Pavlos, R., Moran, E.M., Meyer-Pannwitt, V., Gaudieri, S., D’Orsogna, L., Kalams, S., Ostrov, D.A., Buus, S., Peters, B., Mallal, S. and Phillips, E. (2015) Abacavir-Reactive memory T Cells are present in drug naïve individuals. PLoS ONE, 10 (2). e0117160.

Metushi, I.G., Wriston, A., Banerjee, P., Gohlke, B.O., English, A.M., Lucas, A., Moore, C., Sidney, J., Buus, S., Ostrov, D.A., Mallal, S., Phillips, E., Shabanowitz, J., Hunt, D.F., Preissner, R. and Peters, B. (2015) Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity. PloS one, 10 (5). e0124878.

Martin, J.H., Phillips, E., Thomas, D. and Somogyi, A.A. (2015) Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes. British Journal of Clinical Pharmacology, 80 (5). pp. 929-931.

Saito, Y., Stamp, L.K., Caudle, K.E., Hershfield, M.S., McDonagh, E.M., Callaghan, J.T., Tassaneeyakul, W., Mushiroda, T., Kamatani, N., Goldspiel, B.R., Phillips, E.J., Klein, T.E. and Lee, M.T.M. (2015) Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clinical Pharmacology & Therapeutics, 99 (1). pp. 36-37.

Phillips, E. (2015) Current science and translational opportunities in the prediction and prevention of immunologically-mediated adverse drug reactions. In: 54th Annual Meeting Society of Toxicology (SOT) and ToxExpo, 22 - 26 March 2015, San Diego, CA.

Phillips, E. (2015) Defining and prioritizing unmet research needs for a deadly disease. In: Research Directions in Genetically-mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), 3 - 4 March 2015, Rockville, Maryland.

White, K.D., Chung, W-H, Hung, S-L, Mallal, S. and Phillips, E.J. (2015) Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response. Journal of Allergy and Clinical Immunology, 136 (2). pp. 219-234.

Sterling, T.R., Moro, R.N., Borisov, A.S., Phillips, E., Shepherd, G., Adkinson, N.F., Weis, S., Ho, C. and Villarino, M.E. (2015) Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study. Clinical Infectious Diseases, 61 (4). pp. 527-535.

Phillips, E. (2015) HLA and SCARs: What’s new and What’s next? In: 9th International Congress on Cutaneous Adverse Drug Reactions, 8 June 2015, Vancouver, BC, Canada.

Bourke, J., Pavlos, R., James, I. and Phillips, E. (2015) Improving the effectiveness of penicillin allergy De-labeling. The Journal of Allergy and Clinical Immunology: In Practice, 3 (3). pp. 365-374.

Redwood, A., Jing, L., Tran, T., White, K., Mallal, S., Koelle, D. and Phillips, E. (2015) In search of a virotope: Identification of herpesvirus specific CD8T cells. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Gerace, K. and Phillips, E. (2015) Penicillin allergy label persists despite negative testing. Journal of Allergy and Clinical Immunology, 135 (2). AB113.

Phillips, E. (2015) Personalized approaches to severe immunologically mediated drug reactions: Abacavir hypersensitivity and HLA-B*57:01 as a roadmap for science and translation. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Phillips, E. (2015) Personalized approaches to severe immunologically-mediated drug reactions. In: Future Directions in Personalized Medicine, 5 February 2015, Vanderbilt University, Nashville, Tennessee.

Mallal, S. and Phillips, E. (2015) Personalizing immunology: The immunopathogenesis of severe T-cell mediated drug hypersensitivity. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Phillips, E. (2015) Pharmacogenomics of severe adverse reactions to antituberculous medications. In: NIAID Host Response to TB-HIV Infections, 13 - 14 January 2015, Rockville, Maryland.

Wheatley, L.M., Plaut, M., Schwaninger, J.M., Banerji, A., Castells, M., Finkelman, F.D., Gleich, G.J., Guttman-Yassky, E., Mallal, S.A.K., Naisbitt, D.J., Ostrov, D.A., Phillips, E.J., Pichler, W.J., Platts-Mills, T.A.E., Roujeau, J-C, Schwartz, L.B. and Trepanier, L.A. (2015) Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. Journal of Allergy and Clinical Immunology, 136 (2). 262-271.e2.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Plascensia, P.C., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E.J. (2015) Specific binding characteristics of HLA alleles associate with nevirapine hypersensitivity. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Pavlos, R., Mallal, S., Ostrov, D., Buus, S., Metushi, I., Peters, B. and Phillips, E. (2015) T Cell–Mediated hypersensitivity reactions to drugs. Annual Review of Medicine, 66 (1). pp. 439-454.

Phillips, E. (2015) Translational opportunities in the prediction and prevention of drug hypersensitivity. In: Telethon Kids Research Retreat, 29 - 30 October 2015, Rottnest Island, Perth.

Phillips, E. (2015) Understanding and preventing HLA-associated drug reactions. In: PGRN Retreat, 3 - 4 November 2015, San Francisco, USA.

Gerace, K.S., Karlin, E., McKinnon, E. and Phillips, E. (2015) Varying penicillin allergy testing practices in the United States: A time for consensus. The Journal of Allergy and Clinical Immunology: In Practice, 3 (5). pp. 791-793.

Tseng, A., Seet, J. and Phillips, E.J. (2015) The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future. British Journal of Clinical Pharmacology, 79 (2). pp. 182-194.

Hemler, J.A., Phillips, E.J., Mallal, S.A. and Kendall, P.L. (2015) The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. Annals of Allergy, Asthma & Immunology, 115 (6). pp. 471-476.

2014

Phillips, E.J. and Mallal, S. (2014) Abacavir pharmacogenomics. In: Murray, M.F., Babyatsky, M.W., Giovanni, M.A., Alkuraya, F.S. and Stewart, D.S., (eds.) Clinical Genomics: Practical Applications in Adult Patient Care. McGraw-Hill Professional.

Phillips, E. (2014) Advances in antibiotic allergy. In: Infectious Diseases Grand Rounds, 24 July 2014, University of Melbourne (Austin Health).

Milpied-Homsi, B., Moran, E.M. and Phillips, E.J. (2014) Antiviral Drug Allergy. Immunology and Allergy Clinics of North America, 34 (3). pp. 645-662.

Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E.J. (2014) Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. British Journal of Clinical Pharmacology, 78 (7). pp. 14-23.

Pavlos, R., Mallal, S., Ostrov, D., Pompeu, Y. and Phillips, E. (2014) Fever, rash, and systemic symptoms: Understanding the role of virus and HLA in severe cutaneous drug allergy. The Journal of Allergy and Clinical Immunology: In Practice, 2 (1). pp. 21-33.

Karlin, E. and Phillips, E. (2014) Genotyping for severe drug hypersensitivity. Current Allergy and Asthma Reports, 14 (3).

Keane, N.M., Pavlos, R.K., McKinnon, E., Lucas, A., Rive, C., Blyth, C.C., Dunn, D., Lucas, M., Mallal, S. and Phillips, E. (2014) HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity. AIDS, 28 (13). pp. 1891-1901.

White, K., Gaudieri, S. and Phillips, E. (2014) HLA and pharmacogenetics of drug hypersensitivity. In: Padmanabhan, S., (ed.) Handbook of Pharmacogenomics and Stratified Medicine. Academic Press, pp. 437-459.

White, K.D., Gaudieri, S. and Phillips, E.J. (2014) HLA and the Pharmacogenomics of Drug Hypersensitivity. In: Padmanabhan, S., (ed.) Handbook of Pharmacogenomics and Stratified Medicine. Elsevier, pp. 437-465.

Rive, C., Pavlos, R., Ostrov, D., Plasencia, P., Hung, S-L, Chung, W.H., Peters, B., Buus, S., Mallal, S. and Phillips, E. (2014) HLA class I-drug-T-cell receptor interactions in SJS/TEN. Clinical and Translational Allergy, 4 (Suppl. 3). P2.

Stone, S.F., Phillips, E.J., Wiese, M.D., Heddle, R.J. and Brown, S.G.A (2014) Immediate-type hypersensitivity drug reactions. British Journal of Clinical Pharmacology, 78 (1). pp. 1-13.

Phillips, E. (2014) Models for prevention of drug hypersensitivity. In: 6th Drug Hypersensitivity Meeting (DHM6), 11 April 2014, Bern, Switzerland.

Phillips, E. (2014) Models for prevention of drug hypersensitivity. In: La Jolla Institute for Allergy & Immunology, 3 September 2014, La Jolla, California.

Aung, A.K., Haas, D.W., Hulgan, T. and Phillips, E.J. (2014) Pharmacogenomics of antimicrobial agents. Pharmacogenomics, 15 (15). pp. 1903-1930.

Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E. (2014) Response to letter regarding article ‘Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis’. British Journal of Clinical Pharmacology, 78 (4). pp. 931-932.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E. (2014) Specific binding characteristics of HLA alleles associate with Nevirapine hypersensitivity. In: Conference on Retroviruses and Opportunistic Infections (CROI) 2014, 3 - 6 March 2014, Boston, MA.

Phillips, E. (2014) Strategy and policy cohesion: "The one health agenda: will it deliver". In: Anti-microbial resistance: addressing the one health security agenda, Centre on Global Health Security at Chatham House, 9 December 2014, Murdoch University, Perth.

2013

Lucas, A., Meyer-Pannwitt, V., McKinnon, E., Burrows, S., Rist, M., Leary, S., Lucas, M., Mallal, S. and Phillips, E. (2013) Abacavir impairs an HLA-B*5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope. In: 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), 3 - 6 March 2013, Atlanta, Georgia

Trubiano, J. and Phillips, E. (2013) Antimicrobial stewardshipʼs new weapon? A review of antibiotic allergy and pathways to ‘de-labeling'. Current Opinion in Infectious Diseases, 26 (6). pp. 526-537.

Phillips, E. (2013) Antiretroviral therapy. Internal Medicine Journal, 43 . pp. 11-12.

Phillips, E., Bartlett, J.A., Sanne, I., Lederman, M.M., Hinkle, J., Rousseau, F., Dunn, D., Pavlos, R., James, I., Mallal, S.A. and Haas, D.W. (2013) Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62 (2). e55-e57.

Phillips, E. (2013) Battle advances in war against HIV. West Australian, 20 February 2013 .

Hertz, T., Oshansky, C., Roddam, P., DeVincenzo, J., Caniza, M., Jojic, N., Mallal, S., Phillips, E., James, I., Thomas, P., Halloran, M. and Corey, L. (2013) HLA targeting efficiency correlates with human T cell response magnitude and with mortality from influenza A infection. The Journal of Immunology, 190 (Supp. 1). 49.21.

Hertz, T., Oshansky, C.M., Roddam, P.L., DeVincenzo, J.P., Caniza, M.A., Jojic, N., Mallal, S., Phillips, E., James, I., Halloran, M.E., Thomas, P.G. and Corey, L. (2013) HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proceedings of the National Academy of Sciences, 110 (33). pp. 13492-13497.

Phillips, E.J. and Mallal, S.A. (2013) HLA-B*5701 and flucloxacillin associated drug-induced liver disease. AIDS, 27 (3). pp. 491-492.

Villarino, M.E., Moro, R., Borisov, A., Adkinson, N.F., Phillips, E., Shepherd, G., Ho, C., Weis, S.E. and Sterling, T.R. (2013) Hypersensitivity reactions among persons receiving a 3 month regimen of rifapentine plus isoniazid for treatment of latent tuberculosis infection (LTBI). In: 20th Conference on Retroviruses and Opportunistic Infections (CROI) 2013, 3 - 6 March 2013, Atlanta, Georgia.

Phillips, E. (2013) Pharmacogenomics of drug hypersensitivity in HIV: Evolution of knowledge. In: 8th iSCAR Meeting, 16 - 18 November 2013, Taipei, Taiwan.

Phillips, E. (2013) Prevention and prediction of drug allergy. In: National Institute of Allergy and Infectious Diseases/NIH, Workshop on Drug Allergy, 19 March 2013, Bethesda, Maryland, USA.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing delayed drug hypersensitivity. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing for drug hypersensitivity syndromes. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

2012

Phillips, E. (2012) Abacavir and nevirapine as two distinct models for HLA binding. In: European Association of Allergy and Clinical Immunology: 5th Drug Hypersensitivity Meeting, 14 April 2014, Munich, Germany.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. Journal of the International AIDS Society, 15 (6(Suppl 4)). p. 18119.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. In: 11th International Congress on Drug Therapy in HIV Infection, 11 - 15 November 2012, Glasgow, Scotland.

Lucas, A., Lucas, M., Pavlos, R., Mallal, S. and Phillips, E. (2012) Abacavir reactive HLA-B*5701 restricted memory CD8+ T cells are present in abacavir unexposed donors. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Phillips, E. (2012) Antibiotic Allergy. In: Australasian Society for Infectious Diseases, Annual Scientific Meeting, 24 March 2012, Fremantle, WA.

Hammond, E., McKinnon, E., Glendenning, P., Williams, R., Mallal, S. and Phillips, E. (2012) Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clinical Endocrinology, 76 (2). pp. 201-206.

Phillips, E. (2012) Contemporary approach to antiretroviral therapy: When to start, what to start with and what to switch to. In: Australasian Society for Infectious Diseases, Annual Scientific Meeting, 25 March 2012, Fremantle, WA.

Ostrov, D.A., Grant, B.J., Pompeu, Y.A., Sidney, J., Harndahl, M., Southwood, S., Oseroff, C., Lu, S., Jakoncic, J., de Oliveira, C.A.F., Yang, L., Mei, H., Shi, L., Shabanowitz, J., English, A.M., Wriston, A., Lucas, A., Phillips, E., Mallal, S., Grey, H.M., Sette, A., Hunt, D.F., Buus, S. and Peters, B. (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proceedings of the National Academy of Sciences, 109 (25). pp. 9959-9964.

Pavlos, R., Mallal, S. and Phillips, E. (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 13 (11). pp. 1285-1306.

Pavlos, R. and Phillips, E.J. (2012) Individualization of antiretroviral therapy. Pharmacogenomics and Personalized Medicine, 5 (1). pp. 1-17.

Lee, M.H., Stocker, S.L., Anderson, J., Phillips, E.J., Nolan, D., Williams, K.M., Graham, G.G., Sullivan, J.R. and Day, R.O. (2012) Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status? Internal Medicine Journal, 42 (4). pp. 411-416.

Bourke, J., Pavlos, R., Hollingsworth, P., McLean-Tooke, A., Horimoto, N., O'Brien, V., Edward, E. and Phillips, E. (2012) Penicillin de-labelling in tertiary clinics: Safe and efficacious but incomplete effectiveness. In: ASCIA 23rd Annual Scientific Meeting, 5 - 8 September 2012, Wellington, New Zealand.

Phillips, E. (2012) Pharmacogenomics and dosing individualization. In: Australasian Society of Clinical and Experimental Pharmacology and Toxicology Annual Scientific Meeting, 3 December 2012, Sydney, NSW.

Phillips, E. (2012) Role of pharmacogenomics in the safety of medicine. In: ARCS Scientific Congress, 28 September 2012, Canberra, ACT.

McGettigan, B.D., Hew, M., Phillips, E. and McLean-Tooke, A. (2012) Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. BMJ: Case Reports, 2012 (21 Sept 2012).

Phillips, E. (2012) Translation of pharmacogenetics into the clinic – The immunogenetics example. In: 16th Human Genome Meeting, 13 March 2012, Sydney, Australia.

Phillips, E. (2012) Translation of pharmacogenetics into the clinic: the immunogenetics example. In: Vanderbilt University: Visiting Professorship, Pharmacology Rounds, 21 August 2012, Nashville, TN.

Seet, J.M., Ingram, P.R., Lie, K., Phillips, E.J. and Murray, R.J. (2012) Using antibiotics better: The healthy antimicrobial prescribing initiative (HAPI). In: Australian Society for Antimicrobials 13th Annual Scientific Meeting, 23 - 25 February 2012, Brisbane Convention & Exhibition Centre, Brisbane.

Pompeu, Y.A., Stewart, J.D., Mallal, S., Phillips, E., Peters, B. and Ostrov, D.A. (2012) The structural basis of HLA-associated drug hypersensitivity syndromes. Immunological Reviews, 250 (1). pp. 158-166.

2011

Phillips, E., Keane, N., Blyth, C., Lucas, A., Pavlos, R., Lucas, M., McKinnon, E. and Mallal, S. (2011) Both HLA Class I restricted CD8+ and Class II restricted CD4+T Cells are implicated in the pathogenesis of nevirapine hypersensitivity. In: 51st Interscience Conference of Antimicrobial Agents and Chemotherapy, 17 - 20 September 2011, Chicago, IL.

Phillips, E.J., Chung, W-H, Mockenhaupt, M., Roujeau, J-C and Mallal, S. (2011) Drug hypersensitivity: Pharmacogenetics and clinical syndromes. Journal of Allergy and Clinical Immunology, 127 (3). S60-S66.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E., Huang, J., Riadi, G., Mallal, S. and Jojic, N. (2011) HLA class I binding and its relationship with evolutionary conservation in human proteins and viral proteomes. In: Keystone HIV Evolution Genomics & Pathogenesis, 20 - 25 March 2011, Whistler, British Columbia, Canada.

Phillips, E.J. and Mallal, S.A. (2011) HLA-B*1502 Screening and toxic effects of carbamazepine. New England Journal of Medicine, 365 (7). pp. 672-673.

Phillips, E. (2011) Immunogenetics and immunopathology of drug hypersensitivity. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E.J., Huang, J.C., Riadi, G., Mallal, S. and Jojic, N. (2011) Mapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins. Journal of Virology, 85 (3). pp. 1310-1321.

Haas, D.W., Kuritzkes, D.R., Ritchie, M.D., Amur, S., Gage, B.F., Maartens, G., Masys, D., Fellay, J., Phillips, E., Ribaudo, H.J., Freedberg, K.A., Petropoulos, C., Manolio, T.A., Gulick, R.M., Haubrich, R., Kim, P., Dehlinger, M., Abebe, R. and Telenti, A. (2011) Pharmacogenomics of HIV therapy: Summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clinical Trials, 12 (5). pp. 277-285.

Pirmohamed, M., Friedmann, P.S., Molokhia, M., Loke, Y.K., Smith, C., Phillips, E., La Grenade, L., Carleton, B., Papaluca-Amati, M., Demoly, P. and Shear, N.H. (2011) Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury. Clinical Pharmacology & Therapeutics, 89 (6). pp. 896-901.

2010

Lucas, A.D., Lucas, M., Mallal, S. and Phillips, E.J. (2010) Antigen specific CD8+ T-cells in abacavir hypersensitivity are oligoclonal and CD34lo. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Phillips, E.J. and Mallal, S. (2010) Immunology of drug hypersensitivity reactions. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Phillips, E. (2010) The pharmacogenetics of drug hypersensitivity. In: WorldPharma 2010 – Bridging Basic and Clinical Pharmacology (16th World Congress of Basic & Clinical Pharmacology), 17 - 23 July 2010, Copenhagen, Denmark.

Phillips, E.J. and Mallal, S.A. (2010) Abacavir. In: Wu, A.H.B. and Kiang-Teck, J.Y., (eds.) Pharmacogenomic Testing in Current Clinical Practice. Humana Press, New York, U.S.A, pp. 201-212.

Lucas, A., Lucas, M., Mallal, S. and Phillips, E. (2010) Antigen specific CD8+T cells in abacavir hypersensitiviy can become oligoclonal, CD43Io+/-CD127hi. In: 40th Australasian Society of Immunology Annual Scientific Meeting, 5 - 9 December 2010, Perth, W.A.

McGettigan, B.D., McKinnon, E., Mallal, S., French, M., Hammond, E., Nolan, D. and Phillips, E.J. (2010) Association between low 25(OH) vitamin D levels, antiretroviral therapy and metabolic profile in a cohort of treated ahd therapy naive HIV positive patients in Western Australia. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia.

Phillips, E.J. and Mallal, S.A. (2010) HLA and drug reactions. In: Mehra, N.K., Kaur, G., McCluskey, J., Christiansen, F.T. and Claas, F.H.J., (eds.) The HLA Complex in Biology and Medicine: A Resource Book. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 332-349.

Phillips, E., Lucas, M., Keane, N., Lucas, A., McKinnon, E. and Mallal, S. (2010) HLA-B*35 is associated with nevirapine hypersensitivity in the contemporary Western Australian HIV cohort study. In: 4th International Drug Hypersensitivity Meeting, 22 - 25 April 2010, Rome, Italy.

Phillips, E.J. and Mallal, S. (2010) Pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 11 (7). pp. 973-987.

Hammond, E., Lucas, A., Lucas, M., Phillips, E. and Gaudieri, S. (2010) Vaniprevir: HCV NS3/4A protease inhibitor treatment of hepatitis C. Drugs of the Future, 35 (10). pp. 803-813.

2009

Phillips, E. (2009) Avoiding catastrophic drug toxicities: ‘Drugs that cause hypersensitivity reactions'. In: 2009 Annual Meeting of the American Association of Clinical Chemistry, 22 July 2009, Chicago, Illinois, USA.

Phillips, E. (2009) The pharmacogenetics of drug hypersensitivity: personalizing medicine and predicting the unpredictable? In: WAMSG Medication Safety Symposium, 14 July 2009, Perth, Australia.

Phillips, E. (2009) Human Genes and Adverse Drug Reactions: when genetics meets practical medicine needs: Pharmacogenetics and ADRs: a practical perspective. In: Pharmacogenetics workshop at the Russian Central Scientific Epidemiology Institute., 23 June 2009, Moscow, Russia.

Phillips, E.J. (2009) Drugs that cause hypersensitivity reactions: Personalising medicine & Predicting the unpredictable. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

Phillips, E.J. and Mallal, S. (2009) HLA and drug-induced toxicity. Current Opinion in Molecular Therapeutics, 11 (3). pp. 231-242.

Phillips, E.J. (2009) Overcoming the barrier of clinical translation: The Abacavir example. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Phillips, E.J. and Mallal, S. (2009) Personalizing antiretroviral therapy: is it a reality? Personalized Medicine, 6 (4). pp. 393-408.

Phillips, E.J. (2009) Pharmacogenetic of drug hypersensitivity: Personalising medicine and predicting the unpredictable. In: WAMSG 5th Annual Medication Safety Symposium: ADRs ain'y just ADRs: Action on Adverse Drug Reactions for Medication Safety, 14 July 2009, University Club, University of Western Australia, Crawley.

Kesselring, A.M., Wit, F.W., Sabin, C.A., Lundgren, J.D., Gill, M.J., Gatell, J.M., Rauch, A., Montaner, J.S., de Wolf, F., Reiss, P., Mocroft, A. and Phillips, E. (2009) Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. AIDS, 23 (13). pp. 1689-1699.

Phillips, E.J. and Mallal, S. (2009) Successful translation of pharmacogenetics into the clinic: The abacavir example. Molecular Diagnosis and Therapy, 13 (1). pp. 1-9.

Chaubey, S.K., Sinha, A.K., Phillips, E., Russell, D.B. and Falhammar, H. (2009) Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sexual Health, 6 (3). pp. 254-257.

Mocroft, A., Sterne, J.A., Egger, M., May, M., Grabar, S., Furrer, H., Sabin, C., Fatkenheuer, G., Justice, A., Reiss, P., D'Arminio Monforte, A., Gill, J., Hogg, R., Bonnet, F., Kitahata, M., Staszewski, S., Casabona, J., Harris, R., Saaq, M. and Phillips, E. (2009) Variable impact on mortality of AIDS‐Defining events diagnosed during combination antiretroviral therapy: Not All AIDS‐defining conditions are created equal. Clinical Infectious Diseases, 48 (8). pp. 1138-1151.

Lee, M.H., Anderson, J., Stocker, S.L., Williams, K.M., Graham, G.G., Phillips, E.J., Nolan, D. and Day, R.O. (2009) A tale of two brothers: A familial study of risk factors to allopurinol-induced Stevens-Johnson Syndrome. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

2008

Mallal, S., Hertz, T., John, M., Gaudieri, S., James, I., Phillips, E., Nolan, D. and Jojic, N. (2008) Co-evolution of HLA and viruses: implications and applications. In: Australasian Society for Immunology Meeting, 7 - 11 December 2008, Canberra, ACT, Australia.

Khanam, T., Phillips, E., Lai, T. and Gong, G. (2008) Acetazolamide associated pulmonary oedema in a patient with prior exposure to hydrochlorothiazide. In: 4th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists, 22 - 26 November 2008, Melbourne, VIC.

Phillips, E., Nolan, D. and Mallal, S. (2008) The Authors reply - Response to Vandekerckhove et al & Abel et al. New England Journal of Medicine, 358 (23). pp. 2515-2516.

Almeida, C.M., Martin, A.M., Nolan, D., Lucas, A., Cameron, P.U., James, I., Phillips, E. and Mallal, S. (2008) Cytokine profiling in abacavir hypersensitivity patients. Antiviral Therapy, 13 (2). pp. 281-288.

Phillips, E., Nolan, D., Thorborn, D., Schaefer, M., Laird, R., Rauch, A., Rachlis, A., Shear, N., Knowles, S., Hughes, A., Montaner, J., James, I. and Mallal, S. (2008) Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals. In: 3rd International Drug Hypersensitivity Conference, 11 - 13 April 2008, Paris, France.

Nolan, D., Thorborn, D., Shaefer, M., Laird, R., Montaner, M., Hughes, A., James, I., Mallal, S. and Phillips, E. (2008) Genetic factors predicting abacavir hypersensitivty and tolerance in HLA-B*5701 positive individuals: Combined analysis from PREDICT-1, SHAPE and a multinational study. In: 15th Conference on Retroviruses and Opportunistic Infections (CROI), 3 - 6 February 2008, Boston, U.S.A.

Rauch, A., Thurnheer, C., Fux, C., Nolan, D., Cavassini, M., Chave, J-P, Opravil, M., Phillips, E., Mallal, S. and Furrer, H. (2008) Genetic testing and structured clinical assessment reveal over diagnosis of abacavir hypersensitivity reactions in the Swiss HIV Cohort Study. In: 12th International Workshop on HIV Observational Databases, 27 - 30 March 2008, Malaga, Spain.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J.F., Hay, P., Nolan, D., Hughes, S., Hughes, A., Ryan, S., Fitch, N., Thorborn, D. and Benbow, A. (2008) HLA-B*5701 screening for hypersensitivity to Abacavir. The New England Journal of Medicine, 358 (6). pp. 568-579.

Wannamaker, P., Mallal, S., Phillips, E., Young, B., Brothers, C., Sutherland-Phillips, D., Thorborn, D. and Shaefer, M. (2008) HLA-B*5701 screening reduces abacavir hypersensitivity reactions (ABC HSR): Multiple lines of evidence to establish a new standard of care. In: 18th International AIDS Conference, 3 - 8 August 2008, Mexico City, Mexico.

Saag, M., Balu, R., Phillips, E.J., Brachman, P., Martorell, C., Burman, W., Stancil, B., Mosteller, M., Brothers, C., Wannamaker, P., Hughes, A., Sutherland‐Phillips, D., Mallal, S. and Shaefer, M. (2008) High sensitivity of human leukocyte antigen–B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clinical Infectious Diseases, 46 (7). pp. 1111-1118.

Mallal, S., John, M., Gaudieri, S., Phillips, E. and Nolan, D. (2008) How might understanding of the co-evolution of HLA and viruses inform contemporary clinical issues. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Phillips, E., Hayden, A., Gutiérrez, S., Jahnke, N., Yip, B., Lima, V.D., Hogg, R.S., Harrigan, P.R. and Montaner, J.S.G. (2008) Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply. AIDS, 22 (4). pp. 548-549.

Phillips, E.J. and Mallal, S.A. (2008) Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Current Opinion in Infectious Diseases, 21 (1). pp. 16-24.

Rauch, A., Nolan, D., Thurnheer, C., Fux, C.A., Cavassini, M., Chave, J-P, Opravil, M., Phillips, E., Mallal, S. and Furrer, H. (2008) Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Antiviral Therapy, 13 (8). pp. 1019-1028.

Lo, G., Herrmann, S., Cheng, W., Kontorinis, N., Phillips, E., Nolan, D. and Lucas, M. (2008) Screening for hepatocellular carcinoma (HCC) in hepatitis/HIV co-infection using ultrasound imaging and alfa-feto protein levels. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Herrmann, S., McKinnon, E., John, M., Nolan, D., Martinez, O.P., Phillips, E. and Mallal, S. (2008) Side effects, dosing schedules, pill burden and perceived stress: Interaction and influence on medication adherence. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Chaubey, S., Sinha, A., Phillips, E., Russell, D. and Falhammar, H. (2008) Transient Sick Sinus Syndrome related to Lopinavir-Ritonavir in a patient with AIDS. In: 20th Annual Australasian Society of HIV Medicine Conference, 17 - 20 September 2008, Perth, Western Australia.

Shear, N.H., Milpied, B., Bruynzeel, D.P. and Phillips, E.J. (2008) A review of drug patch testing and implications for HIV clinicians. AIDS, 22 (9). pp. 999-1007.

2007

Raboud, J., Lesosky, M., Sterling, S., Phillips, E.J., Walmsley, S. and Bayoumi, A. (2007) An Estimate of the proportion of symptoms reported in Self-administered questionnaires that are captured as adverse drug events in an observational database. HIV Clinical Trials, 8 (5). pp. 311-319.

Phillips, E.J. and Mallal, S. (2007) Drug hypersensitivity in HIV. Current Opinion in Allergy and Clinical Immunology, 7 (4). pp. 324-330.

Mallal, S., Phillips, E., Carosi, G., Molina, J.M., Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kosyrey, O., Flores, C.J., Hay, P., Nolan, D., Thorborn, D. and Benbow, A. (2007) PREDICT-1: A novel randomized prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Martin, A., Almeida, C.M., Cameron, P.U., Purcell, Anthony W, Nolan, D., James, I., McCluskey, J., Phillips, E.J., Landay, Alan and Mallal, S. (2007) Immune responses to abacavir in antigen-presenting cells from hypersensitive patients. AIDS, 21 (10). pp. 1233-1244.

Nolan, D., Almeida, C. and Phillips, E.J. (2007) Abacavir hypersensitivity. In: Pichler, W., (ed.) Drug Hypersensitivity. S. Karger AG, Basel, Switzerland, pp. 116-125.

Nolan, D., Almeida, C., Phillips, E. and Mallal, S. (2007) Abacavir hypersensitivity. In: Pichler, W.J., (ed.) Drug Hypersensitivity. S. Karger AG, Basel, Switzerland, pp. 95-104.

Nolan, D., Almeida, C. and Phillips, E. (2007) Abacavir hypersensitivity. In: Pichler, Werner J., (ed.) Drug Hypersensitivity. S.Karger AG, Basel, Switzerland.

Phillips, E.J., Uetrecht, J. and Walmsley, S.L. (2007) Antimicrobial agents that act on microbial cell wall formation. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 670-688.

Uetrecht, J., Phillips, E.J. and Walmsley, S.L. (2007) Antimicrobial agents that affect the synthesis of cellular proteins. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 697-711.

Uetrecht, J., Phillips, E.J. and Walmsley, S.L. (2007) Antimicrobial and antifungal agents that act on cell membranes. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 689-696.

Phillips, E., Stasezewski, S., Arribas, J., Fitch, N. and Givens, N. (2007) Characteristics of abacavir hypersensitivity diagnoses according to HLA-B*5701 status and subsequent abacavir patch test result. In: 11th European AIDS Conference, 24 - 27 October 2007, Madrid, Spain.

Phillips, E., Gutiérrez, S., Jahnke, N., Yip, B., Lima, V.D., Hogg, R.S., Harrigan, P.R. and Montaner, J.S.G. (2007) Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients. AIDS, 21 (12). pp. 1561-1568.

Phillips, E.J., Uetrecht, J. and Walmsley, S.L. (2007) Drugs that affect cellular nucleic acid synthesis. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 712-723.

Hammond, E., Almeida, C.M., Mamotte, C., Nolan, D., Phillips, E.J., Schollaardt, T.A., Gill, M.J., Angel, J.B., Neurath, D., Li, J., Giulivi, T., McIntyre, C., Koultchitski, G., Wong, B., Reis, M., Rachlis, A., Cole, D., Chew, C.B., Neifer, S., Lalonde, R., Roger, M., Jeanneau, A. and Mallal, S. (2007) External quality assessment of HLA-B*5701 reporting: an international multicentre survey. Antiviral Therapy, 12 (7). pp. 1027-1032.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Laird, R., Montaner, J., Shear, N., Lucas, A. and Mallal, S. (2007) Genetic characterization of patch test negative patients reporting symptoms after initiation after abacavir. In: 8th International Workshop on Clinical Pharmacology of HIV Therapy, 16 - 18 April 2007, Budapest, Hungary.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Knowles, S., Shear, N., Cavassini, M., Harrigan, R., Montaner, J., Keane, N., Laird, R., Lucas, A. and Mallal, S. (2007) Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Saag, M., Balu, R., Brachman, P., Brothers, C., Stancil, B., Mosteller, M., Wannamaker, P., Sutherland‐Phillips, D., Phillips, E., Mallal, S. and Shaefer, M. (2007) High sensitivity of HLA-B*5701 in Whites and Blacks in immunologically-confirmed cases of abacavir hypersensitivity (ABC HSR). In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Mallal, S. and Phillips, E. (2007) Introduction of pharmacogenetic screening to HIV clinical practice: Potential benefits and challenges. European Infectious Diseases (2). pp. 13-18.

Hammond, E., Almeida, C., Mamotte, C., Nolan, D., Phillips, E., Schollaardt, T., Gill, M.J., Angel, J.B., Neurath, D., Li, J., Giulivi, T., McIntyre, C., Koultchitski, G., Wong, B., Reis, M., Rachlis, A., Cole, D.E., Chew, C.B., Neifer, S. and Mallal, S. (2007) Multi-centre evaluation of HLA-B*5701 allele detection by SSP-PCR typing: a quality assurance initiative. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Tansey, C.M., Louie, M., Loeb, M., Gold, W.L., Muller, M.P., De Jager, J., Cameron, J.I., Tomlinson, G., Mazulli, T., Walmsley, S.L., Rachlis, A.R., Mederski, B.D., Silverman, M., Shainhouse, Z., Ephtimios, I.E., Avendano, M., Downey, J., Styra, R., Yamamura, D., Gerson, M., Stanbrook, M.B., Marras, T.K., Phillips, E.J., Zamel, N., Richardson, S.E., Slutsky, A.S. and Herridge, M.S. (2007) One-Year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Archives of Internal Medicine, 167 (12). pp. 1312-1320.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Flores, C.J., Hay, P., Nolan, D., Hughes, S., Hughes, A., Thorborn, D. and Benbow, A. (2007) PREDICT-1: a novel randomised prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Hughes, S., Parry-Billings, K., Givens, N., Wong, D., Loeschel, E., Parada, P., Hughes, A., Curtis, L., Phillips, E. and Thorborn, D. (2007) Predict-1: A novel randomised prospective study to determine the clinical utility of prognostic screening for HLA-B*5701. In: Canadian Association for HIV Research Annual Meeting 2007, 26 - 29 April 2007, Ontario, Canada.

Uetrecht, J., Phillips, E.J. and Walmsley, S.L. (2007) Principles of antimicrobial therapy. In: Kalant, H., Grant, D. and Mitchell, J., (eds.) Principles of Medical Pharmacology. Saunders. An imprint of Elsevier, Canada, pp. 661-669.

Simor, A.E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H.R. and Kiss, A. (2007) Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant staphylococcus aureus colonization. Clinical Infectious Diseases, 44 (2). pp. 178-185.

Keane, N., Lucas, A., Netto, J., Almeida, C., Martin, A., Marriott, D., Kelleher, A., Phillips, E., Nolan, D. and Mallal, S. (2007) Use of the ELISpot assay to detect abacavir- and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Chui, C.K.S., Brumme, Z.L., Brumme, C.J., Yip, B., Phillips, E.J., Montaner, J.S.G. and Harrigan, P.R. (2007) A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Clinical Infectious Diseases, 44 (11). pp. 1503-1508.

2006

Phillips, E. and Mallal, S. (2006) Predisposition to Drug Hypersensitivity in Patients with HIV. In: 2nd International Drug Hypersensitivity Conference, 18 - 21 April 2006, Liverpool, England.

Phillips, E.J., Larsen, G., Brumme, Z., Harris, M., Toy, J., Harrigan, R., Mallal, S. and Montaner, J.S.G. (2006) Abacavir patch testing and rechallenge in patients labeled with abacavir hypersensitivity syndrome. In: 2nd International Drug Hypersensitivity Conference, 18 - 21 April 2006, Liverpool, England.

Phillips, E., Yip, B., Hogg, R.S., Harrigan, R. and Montaner, J.S.G. (2006) Determinants and outcomes of nevirapine hypersensitivity. In: 2nd International Drug Hypersensitivity Conference, 18 - 21 April 2006, Liverpool, England.

Nolan, D., Phillips, E. and Mallal, S. (2006) Efavirenz and CYP2B6 polymorphism: Implications for drug toxicity and resistance. Clinical Infectious Diseases, 42 (3). pp. 408-410.

Phillips, E.J. (2006) Genetic screening to prevent abacavir hypersensitivity reaction: Are we there yet? Clinical Infectious Diseases, 43 (1). pp. 103-105.

Tailor, S.A.N., Simor, A.E., Cornish, W., Phillips, E.J., Knowles, S. and Rachlis, A. (2006) Glucose homeostasis abnormalities and gatifloxacin. Clinical Infectious Diseases, 42 (6). p. 895.

Tang, P., Walsh, S., Murray, C., Alterman, C., Varia, M., Broukhanski, G., Chedore, P., DeKoven, J., Assaad, D., Gold, W.L., Ghazarian, D., Finkelstein, M., Pritchard, M., Yaffe, B., Jamieson, F., Henry, B. and Phillips, E. (2006) Outbreak of acupuncture-associated cutaneous Mycobacterium abscessus infections. Journal of Cutaneous Medicine and Surgery, 10 (4). pp. 166-169.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Knowles, S., Shear, N., Harris, N., Montaner, J.S.G. and Mallal, S. (2006) Pharmacogenetics and clinical characteristics of patch test confirmed patients with Abacavir hypersensitivity. In: 7th International Workshop on Clinical Pharmacology of HIV Therapy, 20 - 22 April 2006, Lisbon, Portugal.

Phillips, E.J. (2006) The pharmacogenetics of antiretroviral therapy. Current Opinion in HIV and AIDS, 1 (3). pp. 249-256.

Martin, A.M., Krueger, R., Almeida, C.A., Nolan, D., Phillips, E. and Mallal, S. (2006) A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenetics and Genomics, 16 (5). pp. 353-357.

2005

Martin, A., Almeida, C., Nolan, D., Cameron, P., James, I., Purcell, T., McCluskey, J., Phillips, E. and Mallal, S. (2005) Abacavir stimulates Hsp70 redistribution in Antigen-presenting cells of patients with hypersensitivity: Association with Type-I alcohol dehydrogenase activity. In: 12th Conference on Retroviruses and Opportunistic Infections, 22 - 25 February 2005, Hynes Convention Center, Boston, MA.

Mishra, S. and Phillips, E. (2005) Antifungals: What's new? The Canadian Journal of Diagnosis, 22 (1). pp. 81-83.

Martin, A.M., Almeida, C., Nolan, D., Purcell, A., McCluskey, J., Phillips, E. and Mallal, S. (2005) Both the innate and adaptive immune systems are important in the pathogenesis of abacavir hypersensitivity reaction. In: Gordon Research Conference on Adverse Drug Reactions, 5 - 10 June 2005, New London, CT.

Notman, M.J., Phillips, E.J., Knowles, S.R., Weber, E.A. and Shear, N.H. (2005) Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis, 53 (6). pp. 335-338.

Phillips, E.J., Wong, G., Kaul, R., Shahabi, K., Nolan, D., Knowles, S.R., Martin, A.M., Mallal, S. and Shear, N.H. (2005) Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS, 19 (9). pp. 979-981.

Phillips, E.J., Yip, B., Hogg, R.S. and Montaner, J.S.G. (2005) Determinants of and healthcare utilization associated with early discontinuation of abacavir: A case of genetic screening. In: 7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 13 - 16 November 2005, Dublin, Ireland.

Phillips, E.J., Yip, B., Hogg, R.S. and Montaner, J.S.G. (2005) Determinants of and healthcare utilization associated with early discontinuation of abacavir: A case of genetic screening. In: 10th European AIDS Conference, 17 - 20 November 2005, Dublin, Ireland.

van Heeswijk, R.P.G., Cooper, C.L., Foster, B.C., Chauhan, B.M., Shirazi, F., Seguin, I., Phillips, E.J. and Mills, E. (2005) Effect of High-Dose vitamin C on hepatic cytochrome P450 3A4 activity. Pharmacotherapy, 25 (12). pp. 1725-1728.

Harris, M., Alexander, C., Joy, R., Guillemi, S., Phillips, E., Langridge, S., Harrigan, R. and Montaner, J. (2005) Effect of atazanavir (ATZ) and ritonavir (RTV) plasma levels of increasing ATZ/rv daily dosing from 300/100mg to 300/200mg and 400/200mg. In: 6th International Workshop on Clinical Pharmacology of HIV Therapy, 28 - 30 April 2005, Quebec City, Quebec.

Christiansen, F.T., Martin, A.M., Nolan, D.A., Gaudieri, S., Almeida, C., Phillips, E., Cameron, P.U., Moore, C.B., James, I. and Mallal, S.A. (2005) Host MHC influences susceptibility to hypersensitivity reactions to two drugs commonly used in HIV therapy. In: XIX European Immunogenetics & Histocompatibility Conference, 23 - 26 April 2005, Istanbul, Turkey.

Knowles, S.R., Wong, G.A., Rahim, S.A., Binkley, K., Phillips, E.J. and Shear, N.H. (2005) Hydrochlorothiazide-Induced noncardiogenic pulmonary edema: An underrecognized yet serious adverse drug reaction. Pharmacotherapy, 25 (9). pp. 1258-1265.

Mills, E., Foster, B.C., van Heeswijk, R.P.G., Phillips, E., Wilson, K., Leonard, B., Kosuge, K. and Kanfer, I. (2005) Impact of African herbal medicines on antiretroviral metabolism. AIDS, 19 (1). pp. 95-97.

Martin, A.M., Almeida, C., Nolan, D., Cameron, P., Purcell, A., Chessman, D., McCluskey, J., Phillips, E. and Mallal, S. (2005) Involvement of metabolic and immune responses in the pathogenesis of Abacavir hypersensitivity reaction. In: 17th Annual Conference of the Australasian Society for HIV Medicine (ASHM 2005), 24 - 27 August 2005, Hobart, Tasmania.

Mills, E., Wilson, K., Clarke, M., Foster, B., Walker, S., Rachlis, B., DeGroot, N., Montori, V.M., Gold, W., Phillips, E., Myers, S. and Gallicano, K. (2005) Milk thistle and indinavir: A randomized controlled pharmacokinetics study and meta-analysis. European Journal of Clinical Pharmacology, 61 (1). pp. 1-7.

Mills, E., Montori, V., Perri, D., Phillips, E. and Koren, G. (2005) Natural health product-HIV drug interactions: a systematic review. International Journal of STD & AIDS, 16 (3). pp. 181-186.

Martin, A., Almeida, C., Purcell, A., McCluskey, J., Phillips, E. and Mallal, S. (2005) Pathogenesis of abacavir hypersensitivity mediated via stimulation of the innate and adaptive immune systems. In: Gordon Conference on Adverse Drug Reactions, 5 - 10 June 2005, Connecticut College, New London, CT.

Martin, A.M., Nolan, D., James, I., Cameron, P., Keller, J., Moore, C., Phillips, E., Christiansen, F.T. and Mallal, S. (2005) Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts. AIDS, 19 (1). pp. 97-99.

Antoniou, T., Tseng, A.L., van Heeswijk, R.P.G., Walker, S.E., Giquere, P. and Phillips, E.J. (2005) Steady-State pharmacokinetics and tolerability of Indinavir-Lopinavir/R Combination therapy in Antiretroviral-experienced patients. Therapeutic Drug Monitoring, 27 (6). pp. 779-781.

Phillips, E.J. and Knowles, S.R. (2005) Sulfonamide cross-reactivity: Fact or fiction? Annals of Pharmacotherapy, 39 (7). pp. 1372-1373.

Phillips, E. (2005) Using pharmacology in HIV practice: Challenges and strategies. In: 2nd Canadian Therapeutics Congress Joint Scientific Meeting, 13 - 19 April 2005, Vancouver, Canada.

Phillips, E., Alexander, C.S., Harris, M., Guillemi, S., Langridge, S., Scott, A. and Montaner, J. (2005) A retrospective review of protease-inhibitor based therapeutic drug monitoring in an HIV referral centre. In: 6th International Workshop on Clinical Pharmacology of HIV Therapy, 28 - 30 April 2005, Quebec City, Quebec.

2004

Wong, G., Kaul, R., Shahabi, K., Nolan, D., Mallal, S., Knowles, S., Martin, A., Shear, N. and Phillips, E. (2004) Abacavir hypersensitivity syndrome: Results of clinical, immunological and genetic screening. In: 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 25 - 28 October 2004, Washington DC, U.S.A.

Tailor, S.A.N., Simor, A.E., Cornish, W., Phillips, E., Knowles, S. and Rachlis, A. (2004) Analysis of Spontaneous Reports of Hypoglycemia and Hyperglycemia associated with marketed systemic fluoroquinolones made to the Canadian adverse drug reaction monitoring program. Canadian Journal of Hospital Pharmacy, 57 (1). pp. 12-17.

Tang, P., Louie, M., Richardson, S.E., Smieja, M., Simor, A.E., Jamieson, F., Fearon, M., Poutanen, S.M., Mazzulli, T., Tellier, R., Mahony, J., Loeb, M., Petrich, A., Chernesky, M., McGeer, A., Low, D.E., Phillips, E., Jones, S., Bastien, N., Li, Y., Dick, D., Grolla, A., Fernando, L., Booth, T.F., Henry, B., Rachlis, A.R., Matukas, L.M., Rose, D.B., Lovinsky, R., Walmsley, S., Gold, W.L., Krajden, S. and Ontario Laboratory Working Group, The (2004) Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: The Toronto experience. Canadian Medical Association Journal, 170 (1). pp. 47-54.

Martin, A.M., Nolan, D., Gaudieri, S., Phillips, E. and Mallal, S. (2004) Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity. Pharmacogenomics, 5 (6). pp. 643-655.

Martin, A.M., Nolan, D., Gaudieri, S., Almeida, C., James, I., Phillips, E. and Mallal, S. (2004) Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proceedings of the National Academy of Sciences, 101 (12). pp. 4180-4185.

Martin, A., Cameron, P., Nolan, D., James, I., Keller, J., Phillips, E. and Mallal, S. (2004) Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*01 and higher CD4+ T cell counts. In: XV International AIDS Conference, 11 - 16 July 2004, Bangkok, Thailand.

Tailor, S.A.N., Simor, A.E., Cornish, W., Phillips, E., Knowles, S. and Rachlis, A. (2004) Quinolone hyperglycemia and hypoglycemia. Canadian Journal of Hospital Pharmacy, 57 (3). pp. 183-184.

Phillips, E., McGeer, A., Devlin, R., Khan, A., Loeb, M., Katic, M., Kiss, A. and Simor, A. (2004) Randomized controlled trial of combination therapy versus no treatment for the eradication of methicillin resistant Staphylococcus aureus (MRSA) colonization. In: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, 30 October - 2 November 2004, Washington DC, U.S.A.

Knowles, S.R., Phillips, E.J., Wong, G. and Shear, N.H. (2004) Serious dermatologic reaction associated with valdecoxib: Report of two cases. Journal of the American Academy of Dermatology, 51 (6). pp. 1028-1029.

Cameron, M.J., Ran, L., Devries, M., Danesh, A., Persad, D., Xu, L., Bosinger, S.E., Cameron, C.M., Gold, W.L., Willey, B.M., Muller, M.P., Putanen, S.M., Louie, M., Phillips, E.J., Mederski, B.D., Keshavjee, S.H., Low, D.E., Loeb, M., McGeer, A.J. and Brunton, J. (2004) The human pathogenesis of SARS: Gene expression profiling of patients with severe acute respiratory syndrome (SARS). In: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, 30 October - 2 November 2004, Washington DC, U.S.A.

Alexander, C., Montaner, J., Langridge, S., Guillemi, S., Harris, M., Phillips, E. and Harrigan, R. (2004) An interaction between atazanavir/ritonavir (ATV/RTV) and nevirapine (NVP) is observed in a clinical setting. In: 7th International Congress on Drug Therapy in HIV, 14 - 18 November 2004, Glasgow, Scotland.

Heeswijk, R., Khaliq, Y., Gallicano, K., Bourbeau, M., Seguin, I., Phillips, E. and Cameron, D. (2004) The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clinical Pharmacology & Therapeutics, 76 (6). pp. 588-597.

Thistle, P., Gottesman, M., Pilon, R., Glazier, R.H., Arbess, G., Phillips, E., Wald, R.L., Chitsike, I., Simor, A., Chipato, T. and Silverman, M. (2004) A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe. The Central African Journal of Medicine, 50 (9-10). pp. 79-84.

van Heeswijk, R.P.G., Kahliq, Y., Gallicano, K., Bourbeau, M., Seguin, I., Phillips, E. and Cameron, B. (2004) The steady-state pharmacokinetics (PK) of nelfinavir (NFV) and M8 during pregnancy and postpartum. In: 5th International Workshop on Clinical Pharmacology of HIV Therapy, 1 - 3 April 2004, Rome, Italy.

2003

Sullivan, J.R., Rachlis, A. and Phillips, E. (2003) 'Buffalo-hump' dermatitis: A hat trick of antiretroviral side-effects. Contact Dermatitis, 48 (3). pp. 169-170.

Park-Wyllie, L.Y. and Phillips, E.J. (2003) Challenges of adherence management in human immunodeficiency virus pharmacotherapy. Canadian Journal of Clinical Pharmacology, 10 (4). pp. 189-195.

Notman, M.J., Knowles, S.R., Phillips, E.J., Weber, E.A. and Shear, N.H. (2003) Ciprofloxacin skin testing: A retrospective study. In: American Academy of Allergy Asthma & Immunology (AAAAI) 60th Anniversary Meeting, 7 - 12 March 2003, Denver, CO.

Valois, M., Phillips, E.J., Shear, N.H. and Knowles, Sandra R. (2003) Clindamycin-associated acute generalized exanthematous pustulosis. Contact Dermatitis, 48 (3). p. 169.

Loutfy, M., Raboud, J., Thompson, C., Tseng, A., Abdurrahman, Z., Kovacs, C., Rachlis, A., Phillips, E., Rubin, G., Gough, K. and Walmsley, S. (2003) Clinical impact of double protease inhibitor boosting with Lopinavir/Ritonavir and Amprenavir as part of salvage antiretroviral therapy. HIV Clinical Trials, 4 (5). pp. 301-310.

Knowles, S.R., Phillips, E.J., Dresser, L. and Matukas, L. (2003) Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clinical Infectious Diseases, 37 (8). pp. 1139-1142.

Phillips, E.J., Knowles, S.R. and Shear, N. (2003) Cutaneous manifestations of antiviral therapy. Journal of the American Academy of Dermatology, 48 (6). pp. 985-986.

Tailor, S., Knowles, S., Chen, J., Simor, A., Cornish, B., Cornish, P., Rachlis, A., Phillips, E., Gorenstein, F. and Ritchie, M. (2003) Development of a protocol to monitor for ototoxicity in patients receiving long-term aminoglycoside therapy. In: 34th Annual Professional Practice Conference. Canadian Society of Hospital Pharmacists, February 2003, Toronto, Canada.

Phillips, E.J., Rachlis, A.R. and Ito, S. (2003) Digoxin toxicity and ritonavir: A drug interaction mediated through p-glycoprotein? AIDS, 17 (10). pp. 1577-1578.

Koren, G., King, S., Knowles, S. and Phillips, E. (2003) Ribavirin in the treatment of SARS: A new trick for an old drug? Canadian Medical Association Journal, 168 (10). pp. 1289-1292.

Phillips, E.J., Knowles, S.R. and Shear, N.H. (2003) Serum sickness-like reaction associated with clopidogrel. British Journal of Clinical Pharmacology, 56 (5). p. 583.

Antoniou, T., Tseng, A., van Heeswijk, R., Giguère, P., Walker, S. and Phillips, E. (2003) Steady-state pharmacokinetics (PK) and tolerability of indinavir (IDV) when co-administered with lopinavir/ritonavir (LPV/r) in experienced subjects. In: 4th International Workshop on Clinical Pharmacology of HIV Therapy, 28 - 30 March 2003, Cannes, France.

Louie, M., Mazzulli, T., McGeer, A., Phillips, E., Loeb, M., Watt, C. and Simor, A.E. (2003) Transmission of methicillin-resistant Staphylococcus aureus (MRSA) to household contacts. In: SHEA 13th Annual Scientific Meeting, 5 - 8 April 2003, Arlington, Virginia.

Phillips, E., Saskin, R. and Raboud, J. (2003) The prevalence of hyperlipidemia in patients co-infected with hepatitis C and human immunodeficiency virus. In: 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 8 - 11 July, Paris, France.

Phillips, E., Raboud, J. and Saskin, R. (2003) A retrospective cohort study of liver toxicity in hepatitis B and C HIV co-infected patients in the HIV Ontario Observational Database. In: 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 8 - 11 July, Paris, France.

Phillips, E., Raboud, J. and Saskin, R. (2003) A retrospective cohort study of liver toxicity in hepatitis B and C HIV co-infected patients in the HIV Ontario observational database (HOOD). In: 2nd IAS Conference on HIV Pathogenesis and Treatment, 13 - 16 July 2003, Paris, France.

Knowles, S.R., Notman, M.J., Phillips, E.J., Weber, E.A. and Shear, N.H. (2003) The utility of skin testing in suspected clindamycin allergy. In: American Academy of Allergy Asthma & Immunology (AAAAI) 60th Anniversary Meeting, 7 - 12 March 2003, Denver, CO.

2002

Phillips, E.J., Shear, N.H. and Knowles, S.R. (2002) Abacavir hypersensitivity syndrome: A new diagnostic test. In: 5th Annual Research Day. Ontario HIV Treatment Network, 28 - 29 November 2002, Toronto, Canada.

Phillips, E., Knowles, S., Sullivan, J. and Shear, N. (2002) Abacavir hypersensitivity syndrome: A new diagnostic test. In: Canadian Infectious Disease Society Meeting, 1 March 2002, Banff, Alberta.

Phillips, E.J., Kuriakose, B. and Knowles, S.R. (2002) Efavirenz-induced skin eruption and successful desensitization. The Annals of Pharmacotherapy, 36 (3). pp. 430-432.

Phillips, E. (2002) Medication-induced syndromes and adverse drug reactions. In: 2002 North American Congress of Clinical Toxicology Annual Meeting, 24 - 29 September 2002, Palm Springs, California.

Neuman, M.G., Malkiewicz, I., Phillips, E.J., Rachlis, A.R., Ong, D., Yeung, E. and Shear, N.H. (2002) Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency Virus-infected individuals. Therapeutic Drug Monitoring, 24 (6). pp. 728-736.

Phillips, E.J., Knowles, S.R. and Shear, N.H. (2002) Patch testing as a diagnostic modality in patients developing presumed drug-induced hypersensitivity syndromes on abacavir and Nonnucleoside Reverse Transcriptase Inhibitors (NRTIs). In: HIV DART 2002, 15 - 19 December 2002, Naples, Florida.

Phillips, E.J., Bayoumi, A.M., Raboud, J.M., Millson, P., Robinson, G. and Rachlis, A. (2002) Use of lipid-lowering drugs by patients receiving highly active antiretroviral therapy. In: 5th Annual Research Day. Ontario HIV Treatment Network, 28 - 29 November 2002, Toronto, Canada.

Phillips, E.J., Bayoumi, A.M., Raboud, J.M., Millson, P., Robinson, G. and Rachlis, A. (2002) Use of lipid-lowering drugs by patients receiving highly active antiretroviral therapy. In: 11th Annual Canadian Conference on HIV/AIDS Research, 25 - 28 April 2002, Winnipeg, Manitoba.

Phillips, E., Sullivan, J.R., Knowles, S.R. and Shear, N.H. (2002) Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS, 16 (16). pp. 2223-2225.

Tseng, A., Loutfy, M., Phillips, E., Walker, S., Rachlis, A. and Walmsley, S. (2002) The relationship between lipid elevation and lopinavir (LPV) concentration in HIV-infected patients on LPV/r-containing salvage regimens. In: 42nd Annual ICAAC Meeting, 27 - 30 September 2002, San Diego, CA.

Phillips, E., Tseng, A., Loutfy, M., Walker, S., Tailor, S., Harrigan, R., Rachlis, A. and Walmsley, S. (2002) The use of virtual inhibitory quotient (VIQ) in antiretroviral (ART) experienced patients taking amprenavir/lopinavir combinations. In: 5th Annual Research Day. Ontario HIV Treatment Network, 28 - 29 November 2002, Toronto, Canada.

Phillips, E., Tseng, A., Walker, S., Loutfy, M., Walmsley, S., Tailor, S. and Harrigan, P.R. (2002) The use of virtual inhibitory quotient (VIQ) in antiretroviral (ART) experienced patients taking amprenavir/lopinavir combinations. In: 9th Conference on Retroviruses and Opportunistic Infections, 24 - 28 February 2002, Seattle, U.S.A.

2001

Phillips, E., Knowles, S.R., Weber, E.A. and Blackburn, D. (2001) Cephalexin tolerated despite delayed aminopenicillin reactions. Allergy, 56 (8). p. 790.

Phillips, E. (2001) Cost-effectiveness of therapeutic drug monitoring (TDM) of protease inhibitors (PI) in the treatment of HIV. In: 4th Annual Ontario HIV Treatment Netwrok Research Meeting, 10 November 2001, Ontario, Canada.

Phillips, E.J. and Rachlis, A.R. (2001) Digoxin toxicity and ritonavir: A drug interaction mediated through P-Glycoprotein? In: 2nd International Workshop on Clinical Pharmacology of HIV Therapy, 2 - 4 April 2001, Noordwijk, The Netherlands.

Boogaerts, M., Winston, D.J., Bow, E.J., Garber, G., Reboli, A.C., Schwarer, A.P., Novitzky, N., Boehme, A., Chwetzoff, E., de Beule, K. and Phillips, E. (2001) Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving Broad-spectrum antibacterial therapy: A randomized, controlled trial. Annals of Internal Medicine, 135 (6). pp. 412-422.

Risebrough, N. and Phillips, E.J. (2001) Potential cost effectiveness of therapeutic drug monitoring (TDM) of protease inhibitors in the treatment of HIV. In: 2nd International Workshop on Clinical Pharmacology of HIV Therapy, 2 - 4 April 2001, Noordwijk, The Netherlands.

2000

Phillips, E.J., McGeer, A., Rotstein, C., Imrie, K. and Simor, A.E. (2000) Ambulatory treatment of febrile neutropenia (FN): A Canadian survey of current practice. In: 4th International Symposium on Febrile Neutropenia, 16 - 19 December 2000, Brussels, Belgium.

Phillips, E.J. (2000) Approach to hypersensitivity syndromes associated with antiretroviral agents. The PRN Notebook, 5 (4). pp. 14-17.

Phillips, E., Louie, M., Knowles, S.R., Simor, A.E. and Oh, P. (2000) Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic. American Journal of Health-System Pharmacy, 57 (4). pp. 339-345.

Phillips, E.J. (2000) Cutaneous drug reactions associated with antiretroviral drugs. In: Academy 2000: American Academy of Dermatology, 2 - 6 August 2000, Nashville, Tennessee.

Yeung, E., Phillips, E.J., Gardner, S., Leeb, K., Rachlis, A. and Shear, N. (2000) The impact of adverse drug events (ADEs) on subsequent therapy in patients initiating highly active antiretroviral therapy (HAART). In: Canadian Association for HIV Research Annual Meeting 2000, May 2000, Montreal, Quebec.

1999

Phillips, E.J., Knowles, S.R., Shear, N.H. and Weber, E.A. (1999) Cross-reactivity between ampicillin and cephalexin in patients with isolated delayed skin test responses to ampicillin. In: 55th Annual Meeting of the American Academy of Allergy and Immunology, 26 February - March 3 1999, Orlando, FL.

1998

Phillips, E.J., Knowles, S.R. and Shear, N.H. (1998) Allergic reactions to bisphosphonates. In: 67th Annual Meeting of the Royal College of Physicians and Surgeons of Canada, 24 - 27 September 1998, Toronto, Canada.

Phillips, E. and Simor, A. (1998) Bacterial meningitis in adults and children. Postgraduate Medicine, 103 (3). pp. 102-117.

Phillips, E., Feld, R. and McGeer, A. (1998) Infections in myeloma. In: Malpas, J.S., Bergsagel, D.E. and Kyle, R.A., (eds.) Myeloma: Biology and Management (2nd Ed.). Oxford University Press, New York, USA, pp. 439-476.

Phillips, E., Liu, B.A. and Knowles, S.R. (1998) Rapid onset of risperidone-induced hepatotoxicity. Annals of Pharmacotherapy, 32 (7). p. 843.

Phillips, E., Knowles, S., Weber, E. and Shear, N. (1998) Skin reactions associated with bisphosphonates: A report of 3 cases and an approach to management. Journal of Allergy and Clinical Immunology, 102 (4). pp. 697-698.

Phillips, E. (1998) Toxoplasmosis. Canadian Family Physician, 44 (Sept. 1998). pp. 1823-1827.

Einarson, A., Phillips, E., Mawji, F., D'Alimonte, D., Schick, B., Addis, A., Mastroiacova, P., Mazzone, T., Matsui, D. and Koren, G. (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. American Journal of Perinatology, 15 (9). pp. 523-525.

Phillips, E.J., Einarson, A., Mawji, F., D'Alimonte, D., Shick, B., Addis, A., Mazzone, T., Matsui, D. and Koren, G. (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. In: 67th Annual Meeting of the Royal College of Physicians and Surgeons of Canada, 24 - 27 September 1998, Toronto, Canada.

1997

Phillips, E.J., Kumar, B., Oh, P.I., Shear, N.H., Sawka, C., Imrie, K. and Simor, A.E. (1997) Feasibility of outpatient treatment of febrile neutropenia at a Canadian tertiary care centre. In: 3rd International Symposium on Febrile Neutropenia, 10 - 13 December 1997, Brussels, Belgium.

Phillips, E.J. and Keystone, J.S. (1997) Intestinal parasites. In: Rakel, R.E. and Kersey, R., (eds.) Conn's Current Therapy 1997: Latest. Saunders. An imprint of Elsevier, pp. 534-540.

Phillips, E. (1997) The effect of exercise on lymphocyte redistribution and leucocyte function in asymptomatic HIV-Infected subjects. Brain, Behavior, and Immunity, 11 (3). pp. 217-227.

1996

Phillips, E.J., Keystone, J.S. and Kain, K.C. (1996) Failure of combined chloroquine and High-Dose primaquine therapy for plasmodium vivax malaria acquired in Guyana, South America. Clinical Infectious Diseases, 23 (5). pp. 1171-1173.

1995

Phillips, E.J., Ottaway, C.A., Freedman, J., Kardish, M., Li, J., Singer, W. and Fong, I.W. (1995) The effect of exercise on circulating lymphocyte redistribution in asymptomatic HIV-infected subjects. In: 2nd National Conference Human Retroviruses and Related Infections, 29 January - 3 February 1995, Washington DC, U.S.A.

Fong, I.W., Phillips, E.J., Kardish, M., Li, J. and Freedman, J. (1995) The effect of leucocyte function in patients with HIV infection. In: 2nd National Conference Human Retroviruses and Related Infections, 29 January - 3 February 1995, Washington DC, U.S.A.

1994

Phillips, E.J., Willey, B.M., Kapur, V., Musser, J., Low, D.E. and McGeer, A. (1994) PCR-SSCP and automated DNA sequencing used to investigate a cluster of Pneumocystis carinii pneumonia (PCP). In: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 4 - 7 October 1994, Orlando, FL.

1986

Soskolne, C.L., Heyland, D. and Phillips, E. (1986) Human T-lymphotropic virus: Exposure and prognosis. Canadian Medical Association Journal, 134 (6). pp. 575-577.